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Introduction 
The Guidelines of the 4th Joint Societies Task Force on Cardiovascular Disease Prevention in 
Clinical Practice (4th JTF)* were issued in 2007, summarising and evaluating available evidence 
on reducing the incidence of atherosclerotic events arising from coronary heart disease, 
cerebrovascular disease and peripheral arterial disease. The purpose of the guidelines is to 
assist physicians in selecting the best strategies for managing cardiovascular disease. They are 
an important agreed protocol across countries and professionals that have the ultimate aim of 
improving outcomes from the disease. The value of these guidelines depends on the extent to 
which they are used by physicians in daily practice. Introducing the guidelines, the 4th JTF 
authors stressed that ‘implementation programmes for new guidelines form an important 
component of the dissemination of knowledge’.1 
Transferring guidelines from paper into practice has proven to be frustrating for the many  
who endeavour to standardise the management of cardiovascular disease across Europe. The 
EUROASPIRE I, II and III surveys, which audited the practice of preventive cardiology in 
patients with coronary heart disease over a decade, illustrated that patients were not being 
managed to the standards set by the ESC guidelines and that limited attention was given to 
prevention in patients with established heart disease. Evidence of the need for more effective 
lifestyle management was compelling: blood pressure management remained stubbornly 
unchanged, and lipid targets were not achieved in almost half of patients. Other studies report 
disappointing levels of guideline observance among physicians; they are often unaware of 
recommendations given in guidelines and, even when they are, many fail to consistently apply 
them in treating patients.2-3 Commonly cited barriers to guideline adherence among 
physicians include lack of time during consultations, financial constraints and lack of 
confidence in patients’ motivation to comply. Physicians also find that guideline documents 
are difficult to translate into practice.  
To address the gap between publication of guidelines and their use in practice, the ESC at a 
European level organises presentations at conferences for its member national societies and 
key opinion leaders. It works at a political level to promote the prevention agenda and to 
directly influence EU health policy, leading, for example, to the EU Commission endorsement 
of the European Heart Health Charter. However, such efforts must be paralleled by concerted 
strategies at a national level to realise implementation in the front line. The 4th JTF urged 
national societies to develop implementation programmes, starting with the translation of 
                                                     
*
 The 4
th
 Joint Task Force comprised Ian Graham (EACPR), Dan Atar (ESC), Knut Borch-Johnson 
(EASD/IDF Europe), Gudrun Boysen (EUSI), Gunilla Burrell (ISBM), Renata Cifkova (ESH), Jean 
Dallongeville , Guy de Backer (ESC), Shah Ebrahim (ESC), Bjorn Gjelsvik (ESGP/FM/Wonca), Christoff 
Hermann-Lingen (ISBM), Arno W Hoes (ESGP/FM/Wonca), Steve Humphries (ESC), Mike Knapton 
(EHN), Joep Perk (EACPR), Sylvia G Priori (ESC), Kalevi Pyorala (ESC), Zeljko Reiner (EAS), Luis 
Ruilope (ESC), Susana Sans-Mendes (ESC), Wilma Scholte Op Reimer (ESC council on CV Nursing), 
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guidelines to the local language and their adaptation to the national context. It recommended 
that the guidelines issued by the 4th JTF be regarded as a framework from which national 
guidance ‘to suit local political, economic, social, and medical circumstances’ would be 
developed. The recalibration of the SCORE risk assessment charts to reflect mortality and risk 
factor distributions in individual countries as part of this adaptation was emphasised.  
The 4th JTF saw as vital the establishment a multidisciplinary alliance of experts from national 
professional organisations to oversee the adaptation and to drive implementation. It was 
necessary that alliances would have the support of national health authorities and work with 
other sectors such as the medical education and business communities to advance their aims. 
Other recommendations included:  
 An information and education programme aimed at practising doctors that would include 
an audit of practices and feedback. The development of supplementary materials to the 
guidelines, specifically electronic versions for use in hand-held devices, such as PDAs, and 
of A4 sheet versions of risk algorithms and treatment recommendations. 
 A population health approach addressing lifestyle risk factors in general.  
 A public information campaign explaining the concept of multiple risk assessment and 
treatment and intervention thresholds, as well as describing how risk can be reduced. 
Current Report: This report was completed on behalf of the Prevention Implementation 
Committee (PIC) of the European Association of Cardiovascular Prevention and Rehabilitation 
(EACPR), the prevention and rehabilitation-focused association of the European Society of 
Cardiology (ESC), to assess where and to what extent these measures have been pursued in 
different European countries. Acknowledging differing structures, traditions, enablers and 
constraints across European countries, the study sought to evaluate progress in 
implementation, focusing on guideline implementation structures, processes and outcomes. It 
is hoped that the insights gained will provide guidance to the EACPR about how best to 
achieve gains in promoting implementation, as well as informing the 5th JTF in its current 
work of updating the guidelines. 
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Methods 
Country selection 
The aim of this project was to benchmark countries in Europe in terms of their progress in 
implementation of the 4th JTF Guidelines on the Prevention of Cardiovascular Disease in 
Clinical Practice. Countries were selected to illustrate the variety of enablers and barriers to 
applying the guidelines in practice and to maximise potential to generalise the findings. The 
aim was not to randomly select countries in a ‘representative’ manner but rather to identify 
those countries from which most can be learned about the early success or otherwise of rolling 
out implementation. The countries selected were Estonia, France, Germany, Ireland, Italy, the 
Netherlands, Norway, Poland, Romania, Russia, Spain, Sweden and the United Kingdom. 
Study population 
The project was based on in-depth interviews with key personnel in each country. The study 
population comprised the National Coordinator(s) for CVD Prevention and representatives of 
the key organisations active in cardiovascular disease prevention at a national level from each 
of the selected countries. These organisations were identified as the cardiac society, the heart 
foundation(s), the ministry of health and the health service agency/inspectorate, in countries 
where such agencies exist. Our aim was to interview at a minimum one national coordinator 
and one representative from each of the organisations for each country. The interview target 
was 55: 13 national coordinators, 13 cardiac societies, 12 heart foundations (Poland does not 
have a heart foundation ), 13 ministries of health, and 4 national health service 
agencies/inspectorates (Ireland, the Netherlands, Poland and the United Kingdom). Some 
countries have two national coordinators (Germany, Ireland, Italy, the Netherlands, Romania 
and Norway) and some countries have more than one heart foundation (Italy, the 
Netherlands, Sweden and the United Kingdom).  
Research methods 
Participant selection 
A list of the names and e-mail addresses of the national coordinators and contacts in the 
countries’ national cardiac societies and heart foundations was provided by the EACPR, as well 
as the name of one individual each from a health ministry and from a health service agency. 
Contact was initially made with the people on this list. Representatives of health ministries 
and health service agencies/inspectorates (apart from those provided by the EACPR) were 
identified with the assistance of other study participants. 
All were contacted by the research team with a protocol describing the study, alongside a 
letter of invitation from the president of the EACPR and the chair of its Prevention 
Implementation Committee (see Appendix A). Non-responders were contacted again after 
three weeks with a reminder. Arrangements for interview, in person, by telephone or by 
Skype, were made with contacts who agreed to participate.  
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On the premise that an interview in English might be a barrier to the participation of some  
individuals, a short self-completion questionnaire was developed that included the main 
questions covered in the interview. Those who did not respond to the reminder e-mail were e-
mailed a third and final time towards the end of the study.  The questionnaire (in English) was 
attached to this message and an offer to have it translated into the recipient’s own language 
was also made should they be willing to complete it, or have others complete it,   
Interviews 
A country profile of 3–4 pages based on available national documentation was prepared in 
advance of the meetings to guide specific interview questions. This allowed clarification of 
specific actions in each country to be explored. The country profile included sections on the 
population’s CVD and associated risk factor situation; the status of the European Heart Health 
Charter and 4th JTF guideline implementation; the country profile in CVD prevention as 
represented in the Euro Consumer Heart Index and EuroHeart Work Package 5 reports (where 
relevant); information on CVD prevention in primary and second care; and details on national 
CVD prevention policy and strategies as well as a description of the national health system. 
While a set of basic questions on progress in implementation and prevention strategy was 
drawn up, interviews were semi-structured to allow flexibility in following up responses and 
comments made by participants.  
Interviews were mostly face-to-face, with a small number conducted by telephone or Skype. 
Interviews were conducted in English and were recorded with the permission of the 
participant. The duration was 18-128 (average 45) minutes.  
Analysis 
Detailed interview notes were analysed to identify themes and the data were coded 
accordingly. Data were collated to produce a summary for each country. Summaries were sent 
to participants, who were requested to review the material and to correct any errors or 
omissions in the summary. 
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Results 
Response rate 
The following is the response from the efforts made to elicit participation in the study.  In a 
number of cases, individual interviewees represented more than one perspective; for example, 
a national coordinator might speak also on behalf of the national cardiac society. Details of 
such dual representations are shown in the country summaries. 
National coordinators: 19 national coordinators were contacted and 14 of these, from 13 
countries, were interviewed – one from each country, apart from Germany, where two national 
coordinators were interviewed.  
Cardiac societies:  31 cardiac society representatives were contacted, resulting in 9 interviews 
from 9 countries – one each from Estonia, France, Germany, Ireland, Italy, the Netherlands, 
Poland, Spain and Sweden. An interview with the president of the Russian Society of 
Cardiologists was set up; however, he was unavoidably not available on the day arranged. The 
Norwegian Society of Cardiology declined to take part, and there was no response from the 
cardiac societies of Romania and the United Kingdom. 
Heart foundations: 26 heart foundation representatives were contacted, resulting in 11 
interviews from 10 countries – one each from France, Germany, Ireland, the Netherlands, 
Norway, Romania, Russia, Spain, Sweden and the United Kingdom and two from Italy. Poland 
did not have a heart foundation at the time. Two heart foundations in Sweden declined to take 
part as they had no role in guideline implementation. There was no response from the 
Estonian Heart Association. 
Health ministries: 24 representatives of health ministries were approached, yielding 6 
interviews and 2 completed questionnaires from 8 countries – representatives from Estonia, 
Ireland, the Netherlands, Norway, Sweden and the United Kingdom were interviewed, while 
the Polish and Romanian representatives completed a questionnaire. An interview with a 
representative of the Russian ministry was set up; however, she was not available on the day 
arranged. Representatives of the Spanish and German ministries referred us to the national 
cardiac societies. The French ministry contact did not feel competent to talk about guidelines. 
There was no response from the Italian ministry. 
Health service agencies/inspectorates:  3 representatives of health service agencies or 
inspectorates were contacted and  interviewed – from Ireland, the Netherlands and the United 
Kingdom. It was not possible to contact a representative from Poland.  
Detailed summaries integrating the interviews for each country can be found in Appendix B. 
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Discussion 
A diversity of approaches to implementation of the guidelines emerges when the summaries 
for each country are examined. While implementation strategies include components that are 
followed consistently across countries, local constraints – health system structure, culture, 
population health status – have a determining effect on how implementation proceeds and to 
some extent also define what is possible.  
Overall, a positive attitude exists towards the concept of having a uniform set of guidelines in 
operation across Europe. A need to improve efforts in the prevention and management of 
cardiovascular disease both at a clinical and a population level was acknowledged, and the 
guidelines were seen as having an important contribution to this endeavour. It was recognised 
that guidelines already have been significant in improving physician performance and patient 
care. Participants were also satisfied with the scope, credibility and evidence base of 4th JTF 
guidelines. Whatever weaknesses were perceived in guidelines – in the concept, in their 
development, or in the content – guidelines to advise on practice and on wider application to 
population health were welcomed both by physicians and organisations working in the area of 
cardiovascular disease prevention. 
Implementation status 
Ten of the 13 exemplar countries in this study were using the ESC guidelines on prevention at 
a national level, although there was considerable variation in the details of implementation. 
We identified 3 broad approaches: (1) adoption as the national guidelines with local 
adaptation, mainly the adjustment of risk charts to national data (Italy, Poland, Romania, 
Russia and Spain); (2) incorporation into national guidelines along with guidelines from other 
sources (Estonia, Germany and the Netherlands); (3) co-existence with national guidelines 
developed by the health authorities (Sweden and France). It is worth noting that the Estonian, 
German and Dutch national guidelines have incorporated the 3rd JTF guidelines because the 
national guidelines were developed concurrently with the work of the 4th JTF. Lags between 
ESC and national guidelines are likely to occur as countries set their own timetables for 
updates according to their needs. A revision of the Dutch guidance incorporating the 
guidelines of the 4th JTF was in review at the time of writing; Estonia plans to adapt the 5th JTF 
guidelines as national guidelines when they are released.  
The three remaining countries not accounted for here are Ireland, Norway and the United 
Kingdom. In Ireland the 4th JTF guidelines had been endorsed and were used by many doctors, 
and the intention now is to adopt the 5th JTF guidelines as the national guidelines. The roll-out 
of the guidelines in Norway stalled over the issue of recalibrating the SCORE charts to reflect 
Norwegian mortality data, and plans to implement the guidelines were overtaken by a 
government initiative to develop national guidelines that were more appropriate to Norwegian 
needs and conditions. In the United Kingdom, national guidelines had been developed both 
by the joint efforts of professional societies (the Joint British Societies, which include the 
British Society of Cardiology) and by national agencies; in that context, there was no 
imperative to introduce the 4th JTF guidelines. 
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Multidisciplinary alliances 
The 4th JTF recommended as a first step to implementation the formation in each country of a 
multidisciplinary alliance of experts from national professional societies if such an alliance did 
not already exist. In those countries where ESC or ESC-based guidelines are the main ones in 
operation, such coalitions of interest had already been formed in Estonia, the Netherlands and 
Poland, prompted by the publication of the 3rd JTF guidelines; in Spain, a guidelines alliance 
has existed since 2000; in Germany, an existing alliance for prevention took responsibility for 
developing national guidelines; the alliances in Ireland and Russia came together around the 
4th JTF guidelines; and the Romanian alliance was formed after the 4th JTF guidelines had been 
translated and endorsed. The alliance established in the Netherlands limited its task to 
developing national guidelines, and a much broader platform group had taken up the larger 
task of improving the care of cardiovascular patients in that country.  
These alliances were clearly useful in bringing together different professional societies for the 
purposes of agreeing a local version, and with that in mind, similar alliances had been 
established by health authorities in several countries in developing their own national 
guidelines. The buy-in from professional societies has been important, especially as their 
participation created a route to influence member health professionals in daily practice. 
Professional societies participating in these alliances have subsequently played a significant 
role in dissemination, publishing the guidelines in their journals – publication in the national 
cardiac society journal was usual – and presenting the guidelines at meetings and conferences. 
In Romania, for example, a concerted effort was made by the cardiac society to engage with 
GPs and to promote the use of the risk calculator among them. Evidence of ongoing projects 
to raise awareness of the guidelines was scant, however, and the success of these efforts in 
changing habitual practices, especially among GPs, was unknown – many participants believed 
that ignorance of the guidelines or failure to apply them was common among practitioners.  
The absence of multidisciplinary alliances in France, Italy and Sweden was not seen as a 
barrier to implementation by participants from these countries. In France and Sweden, 
national guidelines take precedence over the ESC guidelines and in this state of co-existence, 
it might well be inappropriate for a separate body to seek to promote its guidelines within the 
same health system.  
Health authority support 
Effective as these alliances might be, without the participation of health authorities, or at least 
their active support, alliances lack the necessary authority for the systematic implementation 
of prevention guidelines throughout national health systems. Strong leadership on 
cardiovascular disease within the health system can have an enormous positive impact – in 
England, where a ‘Heart Tsar’ has been in position for several years, cardiovascular disease is 
no longer the main killer. The presence of health authorities or agencies in the 
implementation of the 4th JTF guidelines was observed at some level in a number of countries. 
In Spain, the health ministry established and funded the alliance for implementation; in 
Estonia, the guidelines were approved and are supported by the health insurance fund; and in 
Ireland, the health ministry is represented on the alliance. In France, Norway, Sweden and the 
United Kingdom, agencies reporting to the health ministry initiated and oversaw the 
development of national guidelines, distinct from those issued by the ESC. Health authorities 
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have the supreme power in implementation when payment of service providers is tied to 
guideline adherence as in Estonia and the United Kingdom, and in the Netherlands, too, when 
and if the new payment structure for prevention in primary care is taken up. It was noted, for 
example, that in the United Kingdom adherence to the NICE guideline was high among GPs 
because it was tied to remuneration. Among those countries where the ESC guidelines were 
the main guidelines in use, active health authority support for guideline implementation was 
not apparent -  for instance in Germany, Italy, Poland, Romania or Russia.  
Health authorities may support only or mainly those guidelines that they have mandated, so 
those that develop separate national guidelines promote those guidelines, perhaps to the 
exclusion of ESC guidelines, as has occurred in Norway and the United Kingdom. Where the 
ESC guidelines co-exist with national guidelines, it is likely that physicians will adhere to 
treatment thresholds set in national guidelines when these differ from ESC recommendations 
because insurers reimburse treatment on the basis of national guideline thresholds. This is the 
case in France, where the national guidelines have priority and those issued by the ESC are 
used mainly by cardiologists. Such regulation obliges physicians to follow national guidelines 
regardless of their judgement – for example, when pharmacological intervention might be 
appropriate for some patients below the threshold. In Sweden, where national, regional and 
local guidelines operate alongside the ESC guidelines, it seems that the latter fill a gap as they 
address more directly an audience of medical professionals. The Swedish cardiovascular 
prevention guideline is part of an all-encompassing cardiac care guideline, which is targeted 
chiefly at decision-makers. In this context, while the national guidelines take precedence, the 
ESC guidelines serve as a useful reference.  
Participation of health authorities in the implementation process does not represent an 
unqualified commitment to cardiovascular disease prevention, and countervailing agendas 
operate in other quarters at the political level. Study participants noted factors that influenced 
government, such as ideological beliefs in personal responsibility for lifestyle (the 
Netherlands); reluctance or perhaps inability to commit funding to support prevention 
activities (the ending of support for screening services in Ireland, Norway and Romania); an 
unstated imperative to maintain the revenues accruing from taxes on tobacco and alcohol 
(France); and the vested interests of the tobacco, agriculture and food industries operating in 
national parliaments (France and Germany). The difficulties researchers for this study 
encountered in identifying officials responsible for CVD management and prevention in 
health ministries, even when assisted by other national participants, and in the low level of 
participation by those individuals when identified, suggested a substantial lack of focus on 
prevention of CVD at a political level.  
In many countries surveyed, health care was heavily devolved to regional administrations that 
have responsibility for the realisation of policy in day-to-day health care practice. This added 
another tier of complication to implementation efforts and demands the multiplication of 
relationships with local bureaucracies if alliances are to operate at a regional level in these 
countries. To complicate matters further, in some of these countries, there was no official with 
specific responsibility for cardiovascular disease management appointed at regional 
administrative level, so identifying the official with whom to engage became a challenge in 
itself for an implementation group. It was a major objective of the alliance in Spain to set up 
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partnerships with regional health ministries, but little other evidence of links being 
established with regional administrations emerged from our interviews. 
Participation from other sectors 
In addition to advising that implementation alliances seek the support of health authorities, 
the 4th JTF advised that they should form relationships outside the health sector with those 
sectors that have a stake in implementation endeavours, in particular the medical education 
and business sectors. It was not apparent that such links had been established, apart from in 
Ireland, where the alliance was planning to involve the medical colleges in the 
implementation process. Industry, specifically tobacco and food, was overwhelmingly seen as 
an obstacle to disease prevention endeavours. In addition, criticism was levelled at the 
influence of the pharmaceutical industry upon the setting of priorities in prevention and 
guiding them in favour of pharmacological treatment.  
Evaluation  
An implementation process is likely to remain an exercise in distribution unless the adherence 
of practitioners to the guidelines in daily practice is assessed. The extent to which practice was 
evaluated varied in the countries we examined. Evaluation mechanisms were most apparent in 
countries where guidelines formally underpin practice within the health system or where 
payment is tied to guideline adherence, as in France, the Netherlands, Estonia, Sweden and 
the United Kingdom. In these countries, state agencies or insurance funds have a monitoring 
function. However, this is not without exception - in Norway and Spain, where health 
ministries had formally supported the national guidelines, monitoring of adherence had not 
been undertaken.  
Agencies of state and insurance funds monitor only national guidelines. Where ESC guidelines 
coexist with separate national guidelines – France and Sweden – and in countries where ESC-
based guidelines are the principal guidelines in use but health authority support for guidelines 
was more muted – Germany, Ireland, Italy, Poland, Romania and Russia – no evaluation of 
adherence had been conducted. It seems beyond the resources of implementation alliances or 
cardiac societies to conduct audits of practitioner behaviour, which suggests that they need 
support to embark on any such endeavour. Notably, the Estonian Society of Cardiology, 
together with the National Audit Office, had conducted an audit of GP screening for CVD risk 
factors and follow-up with hypertensive patients. Where state agencies do not lend that 
support, there may be a role for the ESC to provide support, as a way to close the loop of 
issuing guidelines, implementing them in practice, and auditing their implementation.  
Reaching practitioners 
Building a mechanism to evaluate practitioner adherence might serve to motivate doctors to 
engage in prevention. Feedback is an important device for changing behaviour and the ability 
to benchmark their performance against their peers would highlight where physicians need to 
improve their practices. Several participants expressed dissatisfaction at the emphasis in 
healthcare on reacting to the acute disease to the detriment of pursuing prevention in daily 
practice. This focus begins in a practitioner’s medical training and continues in the career 
paths that mould physicians. The attitudes of physicians both in primary and secondary care 
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may undervalue prevention, and it was acknowledged that the process of changing the 
professional practices of doctors would be slow. The shift to supporting patients in changing 
behaviour poses a challenge to doctors familiar with diagnosing disease and prescribing 
medication, and they may lack of confidence in their ability to be effective in the area of 
lifestyle change. Are financial incentives the answer to changing physician orientation towards 
prevention? Mixed feelings were expressed by participants on this question. Some believed 
that progress was contingent on remuneration of physicians for their prevention practices. 
Others viewed prevention as the professional responsibility of physicians, where financial 
incentivisation should not be necessary. 
Guideline challenges 
The process of implementation may be hampered to some extent by the unwieldy nature of 
the guidelines, and some participants felt that improving the quality of the document was key 
to implementation. The more user-friendly the guidelines, the more they would be used. The 
complaint was made repeatedly in interviews that the guidelines were too long and too dense 
for practitioners to reference and memorise, and particularly impractical for 10-minute patient 
consultations. It was also felt that technical discourse of the guidelines doesn’t equip doctors 
with the types of messages that are meaningful to the general public and that can be conveyed 
patients during consultations. 
Guideline fatigue was a factor cited by many participants as an impediment to physicians 
embracing the guidelines. This is particularly an experience of general practitioners, who 
encounter the full range of medical conditions in their work and are expected to be abreast of 
the guidelines on all. The situation is exacerbated by continuous updating so that no sooner 
have doctors become familiar with a set of a guidelines that they have to revise their 
knowledge with a new set. While it was acknowledged that revision of guidelines is 
unavoidable in the light of new evidence, the necessity of such frequent revisions was 
questioned. In this deluge of multiple and ever-changing guidelines, doctors feel 
overwhelmed. 
Fatigue is aggravated by conflicts between guidelines issued by different societies and the 
tendency of different societies to emphasise the particular risk factor that is their concern. The 
2009 ESH guidelines on hypertension, and their inconsistency with the prevention guidelines, 
were mentioned in this context. Particularly irksome were inconsistent guidelines issued by 
the same organisation. Such conflicts were seen to undermine the credibility of experts and 
impede acceptance of the guidelines among practitioners. It was felt that conflicting 
recommendations offered an easy excuse to practitioners to make subjective decisions, and 
participants felt that one target figure should be set by all for each risk factor. 
It was widely suggested that the guidelines needed to give greater priority to the reduction of 
lifestyle risk factors and to acknowledge that treatment alone will not achieve desired 
reductions in cardiovascular risk. There was some concern that the emphasis on treatment 
was a result of the influence of pharmaceutical companies on the decisions made by guideline 
committees, although it was accepted the tendency to favour approaches that are 
underpinned by evidence-based research is normal among scientists. Additionally, many 
participants felt that the guidelines should extend beyond high-risk patients to address 
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cardiovascular prevention at the population level, and that the ultimate aim must be to 
maintain and increase cardiovascular health for the majority of people at low risk.      
Participants from several countries expressed misgivings about the reliability of the SCORE 
risk charts. They cited such weaknesses as the inability of the tool to identify total risk in 
younger individuals with substantial lifestyle and clinical risk factors; the potential to 
unnecessarily medicalise the care of healthy older people; and the overestimation of risk in 
low-risk populations. The usefulness of the message derived from risk calculation on a 
patient’s total risk was questioned. In addition, the inability to estimate morbidity risk was 
also seen as a drawback and it was felt that this might be more meaningful to patients.  
SCORE has not been adopted in all countries that use the ESC guidelines. The French Society 
of Cardiology encountered strenuous resistance to the tool from other professional societies 
and did not continue efforts to promote it. Italy developed its own risk assessment tool within 
the framework of its national disease prevention plan. 
Role of the ESC 
The authors of the 4th JTF acknowledged that both the full guidelines and the executive 
summary were too long for routine use, and it was suggested that national societies develop 
quick-reference, single-page sheets and electronic versions of the guidelines. In Ireland,  a 
reference sheet is being developed by the national prevention group. While several 
interviewees proposed that such quick-reference-type formats would be very useful, many 
suggested that the ESC should produce them. The work involved, as well as the financial costs, 
no doubt discourage national groups from undertaking such projects. The French Society of 
Cardiology relied on sponsorship of a pharmaceutical company to publish a French version of 
the 2008 ESC compendium, while the cost of a French version of the 2010 ESC compendium 
proved to be prohibitive. Some interviewees proposed that implementation endeavours would 
be aided by making the pocket version freely available on the ESC website,  since they have 
been in circulation for three years. National groups may need more support and guidance 
from the ESC if they are to undertake the task of producing accessible versions of the 
guidelines for their local audiences.  
Developing regional versions of SCORE has proven to be another stumbling block to 
implementation. In Norway, it was reported that SCORE was not progressed because the 
cardiac society did not receive timely support from the ESC to recalibrate the SCORE charts 
using Norwegian data. Participants from Russia reported a similar problem. These experiences 
highlight that while the ESC focuses its efforts on delivery of guidelines, countries clearly 
struggle with the dissemination requirements that ensue. Furthermore, rightly or wrongly, 
they expect that the ESC should support regional activities to develop resources such as 
SCORE. Some rebalancing of the ESC focus may be warranted, so that some of the effort 
dedicated to improving guidelines might be redirected at getting them into practice.  
It is worth considering in this context suggestions made by participants on the adaptation of 
the guidelines. It was suggested that a basic European version of the guidelines be produced 
that would facilitate and standardise national adaptations and elaborations. It was also 
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proposed that a methodology for adapting guidelines be described by the next joint task force 
to guide national task forces in these endeavours. 
Several participants suggested not only more user-friendly and usable guidelines for 
practitioners, but also that ESC should address prevention at a population level and develop 
guidelines for the general public. Should the ESC seek to widen its brief? Other participants 
felt the ESC should maintain a more limited role as provider of the scientific underpinning of 
national health strategies. And this would seem to have been how the 4th JTF perceived the 
ESC role, while it acknowledged the need for population health strategies, it indicated that 
this was a political responsibility: “[the guidelines] should be complemented by national and 
European public health strategies aimed at whole populations in a co-ordinated and 
comprehensive effort to reduce the enormous burden of CVD that afflicts European 
populations.” 
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Recommendations  
Considerations for the ESC 
One of the strongest messages that emerged from feedback was that more is expected of the 
ESC by those that look to it to take a lead in prevention. In particular, they asked the ESC to 
produce simpler guidelines that can be used in practice, concrete advice that can be passed on 
to patients, and guidelines for the population. Clearly there is a need for more material to 
supplement the ESC’s main offering, but where does the ESC responsibility for this end and 
that of the national societies begin? It is arguable whether the requirements of different 
countries will vary to such an extent that national societies should play the major role in 
producing local adaptations. Such work can be demanding of time and money – producing a 
one-page reference sheet for doctors is probably affordable, but collateral such as user-friendly 
publications complete with colour and illustrations are higher cost. Once produced, the 
material must be distributed to its audience. As noted earlier, a first step would be to provide 
the pocket guidelines for download free of charge once a reasonable period of time has elapsed 
so that all physicians would at least have access to a usable set of guidelines. It would be useful 
also for the ESC to consider whether developing a ‘skeletal’ set of guidelines and providing 
enhanced support for national groups to adapt these guidelines to local needs might meet the 
requirements of both sides.  
The issue is broader than guidelines, however. The ESC must also consider its role in 
providing further support to countries on implementation as a whole. It is not clear that the 
resources and the skills required to back up a wide-ranging implementation strategy can easily 
be accessed at a national level. Several of the elements of the recommended implementation 
package were not achieved. For example, many countries had not made a start in the 
evaluation of progress in guideline implementation, promotion of the guidelines had not been 
an ongoing project, and success at securing the support of health authorities was variable. 
While the 4th JTF outlined the rational steps that needed to be taken, there was no follow 
through with national societies and alliances, and merely handing over ideas to others was not 
proven to be an effective strategy for getting those ideas put into practice. By shifting its focus 
from producing the best guidelines based on the latest evidence to doing more work with 
national groups on implementing the guidelines, the ESC might well gain more in terms of 
improving cardiovascular disease outcomes. A measure such as bringing national coordinators 
and stakeholder representatives together for the purposes of formulating practical strategies 
would help in developing the support networks that activists at a national level need. If the 
ESC supported even small-scale audits, feedback from these might act as a catalyst to health 
ministries to play a greater role in implementation. 
Another matter to reflect on, related to the publication of guidelines for the general public, is 
whether the ESC ought to widen its brief and concern itself with the prevention of 
cardiovascular disease at population level. The position of the ESC to date has been to address 
its message to physicians and leave responsibility for communicating to the public to health 
authorities and non-government organisations. It may be increasingly hard to resist the pull 
towards a wider population brief, however. The imperative of disease prevention has gained 
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currency in health ministries across Europe and, however slowly they may be to take concrete 
steps in this regard, focussing narrowly on the acute disease may soon be out of step with 
political mindsets.  
Considerations on the guidelines  
Different versions of the guidelines are needed to meet the requirements of practitioners in 
different contexts. While the full version and executive summary remain important 
documents for those who want access to the scientific basis of recommendations, a demand 
exists for more flexible formats:  a 1-page reference with algorithms for diagnosis and decision-
making; computer-based decision support systems; an accessible version that is easy for 
practitioners to digest. There is also a need to provide physicians with guidance written in the 
language and including the concepts that they can use with their patients, such as the advice 
for patients to walk 10,000 steps a day. Providing such material might also encourage 
physicians to counsel patients in lifestyle change. 
The next guidelines task force must decide whether to shift the balance in recommendations 
towards addressing lifestyle risk factors in addition to pharmacological interventions. This 
might increase the challenge of guideline adherence among physicians who prefer the 
traditional role of prescribing medication and who are hesitant to engage in lifestyle 
counselling, yet there was substantial support for this rebalancing among participants. On a 
related point, the task force should consider whether to broaden the remit of guidelines 
beyond high-risk patients to take account of prevention in the population. 
A concerted effort must be made to standardise guidelines across scientific societies. A single 
set of targets for all risk factors would remove one source of frustration for practitioners and 
remove one source of inconsistency in treatment. 
Considerations for stakeholders 
Many of the barriers to implementation of the guidelines are structural: the organisation of 
health systems and the contracts under which practitioners operate serve to impede changes 
in practice. It is critical for national coordinators to gain the active support of health 
authorities to overcome these barriers. To this end, national coordinators must make greater 
efforts to identify the key personnel within ministries that have the power to make a 
difference and to endeavour to secure their support. They might look for guidance to other 
organisations that have had success in securing ministry support for tackling other diseases. 
Such work is demanding, so it is equally critical for cardiac societies to appoint national 
coordinators who are able and willing to undertake it.  
Efforts need to be made to focus physicians more on prevention. Physician training,  starting 
in undergraduate education, emphasises the treatment and curing of disease, and the career 
paths that most physicians follow subsequently reinforce that orientation. The task of 
prompting physicians to engage more in prevention and to counsel patients in lifestyle change 
is considerable. In this context, the merit of linking practitioner payment to prevention must 
be considered, and whether implementation alliances should press for this in their 
engagements with health authorities. The concept of working with patients to gain their buy-
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in should also be pursued, to agree plans with them on adhering to medication regimes and 
lifestyle improvement.  
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Summary Recommendations  
1. In relation to the ESC, the organisation should consider the following: 
i. Redefining where to assign responsibilities in the guideline implementation process 
between the European organisation and the national alliances.  
ii. Changing the relative emphasis in its activities from the regular updating of guidelines  
in favour of driving the implementation of these guidelines. 
iii. Increasing its efforts to work with national alliances, both individually and as a group, in 
developing implementation strategies. 
iv. Providing more resource support to national alliances to ensure that key components of 
guideline implementation, such as auditing practice, are achieved.  
v. Widening its brief to address cardiovascular prevention at population level.  
2. In relation to the guidelines, the ESC should consider the following: 
i. Developing a variety of guideline formats for use by practitioners in different contexts, 
with emphasis on greater simplicity and flexibility.  
ii. Providing practitioners with guidance that uses the language and concepts accessible to 
a public audience that they can communicate to patients. 
iii. Rebalancing guideline recommendations towards addressing lifestyle risk factors in 
addition to pharmacological treatment. 
iv. Broadening the scope of the guidelines beyond high-risk patients to include prevention 
in the population. 
v. Standardising guidelines across scientific societies so all recommend the same targets. 
3. National cardiac societies should appoint national coordinators who have the skill and 
commitment to undertake a key role in driving implementation. 
4. National coordinators should work to secure the support of key personnel within health 
ministries, with the aim of gaining the active involvement of health ministries in guideline 
implementation. 
5. Implementation alliances should consider whether to endorse the linking of practitioner 
payment to prevention actions and whether to recommend this to national health 
authorities.   
6. Stakeholders as a whole should consider: 
i. Focussing physicians more on prevention, starting from training and throughout their 
careers. 
ii. Gaining the active participation and commitment of patients in the management of their 
cardiovascular disease.  
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Appendix A: Mailshot Documents 
Letter of invitation 
 
 
 
 
 
 
Address for correspondence: 
Dr Karen Morgan 
Department of Psychology 
Division of Population Health Sciences 
Royal College of Surgeons in Ireland 
123 St. Stephen’s Green 
Dublin 2 
Ireland 
 
Dear Colleague, 
The European Association for Cardiovascular Prevention and Rehabilitation (EACPR) has 
commissioned a study to evaluate progress in the implementation of the Fourth Joint 
European Societies’ Task Force Guidelines on Cardiovascular Disease Prevention in Clinical 
Practice across Europe. A brief protocol describing the study is attached with this letter. The 
study will examine the structures and processes that have been established in different 
European health-care systems to translate the guidelines into clinical practice, with the aim of 
illustrating the variety of enablers and barriers to guideline implementation. The study will be 
based on in-depth interviews with key personnel in each of the selected national systems.  
Your country has been chosen as one of twelve exemplar countries to participate in the study, 
and we would very much appreciate your input as you have a key perspective on your 
country’s implementation. The EACPR has appointed a research team led by Professor 
Hannah McGee from the Royal College of Surgeons in Ireland to conduct the study. Interviews 
will be conducted by Dr Karen Morgan, an experienced health and organisational 
psychologist, who will arrange a suitable time and location for interview with participants. 
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Participants will be asked to provide key national documents of relevance to prevention 
implementation for consideration in advance of the interview. 
The purpose of the study is to characterize the collective experience of guideline 
implementation in Europe, and the research will be conducted in a way that values 
experiences in each of the participating countries.  The findings will recognise differing 
structures, traditions, enablers and constraints across countries and will not seek to rank 
countries in terms of progress.  
We would be extremely grateful  for your support in facilitating this study,  the findings of 
which will strengthen the evidence base for advocacy on the implementation of CVD 
prevention at European and national levels.  
Should you wish to contact Dr Morgan, her contact details are as follows: telephone +353 1 
402-2365; e-mail kmorgan@rcsi.ie.  
 
Yours sincerely, 
  
_____________________ ______________________ 
Prof. Pantaleo Giannuzzi Prof. Ian Graham 
President, EACPR Chair, EACPR Prevention Implementation Committee 
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Study protocol 
 
Evaluation of the Implementation of the Fourth Joint European 
Societies' Task Force Guidelines on Cardiovascular Disease 
Prevention in Clinical Practice 
 
Study Protocol 
 
Background: The Fourth Joint Societies’ Task Force (4
th
 JTF) Guidelines on Cardiovascular Disease 
Prevention in Clinical Practice are an important agreed protocol across countries and professions to 
improve patient care in line with the best up-to-date evidence. The value of these guidelines depends 
on how much they are implemented. This project aims to assess where and how much the guidelines 
have been implemented. The study is planned on behalf of the European Association of 
Cardiovascular Prevention and Rehabilitation (EACPR). The EACPR is the prevention- and 
rehabilitation-focused association of the European Society of Cardiology (ESC).  
Acknowledging differing structures, traditions, enablers and constraints across European countries, 
the research will evaluate progress in implementation of the 4
th
 JTF Guidelines in twelve European 
countries, focusing on guideline implementation structures, processes and outcomes. The twelve 
‘exemplar’ countries will be selected to maximise the usefulness of the findings and subsequent 
recommendations to the EACPR/ESC. 
  
Research Outline 
Study population: Key personnel in selected countries will be identified (e.g., representatives of the 
national cardiac society and heart foundation; health policy-makers and service providers). Twelve 
countries will be identified following consultation with the EACPR Board. The aim is not to randomly 
select countries in a ‘representative’ manner but rather to select countries from which we can learn 
most about the early success or otherwise of rolling out implementation.  
Research methods: Each selected organisation will be invited to provide a rapporteur to take part in 
an in-depth interview. The interview team will request copies of key national documents of relevance 
to prevention implementation in advance of the visit. On average, four key personnel representing 
different aspects of the national system will be involved in interviews to obtain a multi-faceted 
perspective. The interview schedule will be a general set of questions on progress towards 
implementation, using a structured organisational model. A ‘five years back, five years forward’ 
approach to considering change will also be used. A country profile based on available national 
documentation will be prepared in advance of the meetings to guide specific interview questions. This 
will allow clarification of specific actions in each country to be undertaken with key personnel.  
Research outcomes: Research findings will be discussed with those having taken part and with the 
relevant committee in EACPR – the Prevention Implementation Group – in order to best interpret the 
findings across countries and to identify the factors most supporting implementation of the Guidelines. 
Work will be undertaken in early Summer and Autumn of 2010 – with discussion among experts at the 
ESC Congress in August in Stockholm. The lessons to be taken from implementation activities to date 
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will be presented to a wide audience, in order to advance patient care, at at the European Summit on 
CVD Prevention to be held at the European Heart House, Nice, on 30 November, 2010. 
Team: The project will be led by Professor Hannah McGee, FESC (Royal College of Surgeons in 
Ireland (RCSI)) and Board of the EACPR and Dr Karen Morgan (RCSI), an organisational 
psychologist and change management consultant who works in cardiovascular services evaluation.  
INVITATION: It is important to have a wide range of countries participating. If your country is 
selected, we hope you will be able as a key stakeholder to provide relevant documentation and to 
participate in an interview. We will share the information obtained with participants both as a means of 
cross-checking interpretations during the study and as a resource to participants after the study.  
For any questions, contact details for Dr Morgan are as follows: 
Telephone: + 353 1 402-2365  
E-mail: kmorgan@rcsi.ie  
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Appendix B: Country Summaries 
Estonia 
1. Interviewees 
National coordinator Prof. Margus Viigimaa 
Cardiac society Prof. Margus Viigimaa, Estonian Society of Cardiology 
Health ministry Dr Sirje Vaask, specialist in disease prevention, Estonian Health 
Insurance Fund  
Consultation Gaps 
 Heart foundation: Efforts to make contact with a representative of the Estonian Heart 
Foundation failed. 
2. Health system 
The Estonian health system is a largely public system, where over two-thirds of funding comes 
from national health insurance and a further 12% from general taxation. Health care is 
financed by mandatory social tax contributions (health insurance), other government tax 
revenues, and out-of-pocket payments. The population coverage by health insurance is quite 
broad and covers contributors’ dependants. All publicly funded health-care providers are 
contracted by the Estonian Health Insurance Fund (EHIF). The Ministry of Social Affairs 
supervises the health system, which comprises numerous actors including various agencies 
under the ministry, public independent bodies such as the EHIF, private primary care units 
and mainly publicly owned hospitals, as well as NGOs and professional bodies. The Estonian 
National Health Plan 2009-2020 brings together the main strategic goals of Estonian health 
system. 1 
3. Cardiovascular risk factors in the population 
Smoking: 46% of men and 25% of women aged 16–64 years are current smokers.2 
The smoking rate is high in Estonia. It is decreasing among men, but rising among women and 
young people. Regulation of smoking is strict, and it has been banned in public places 
including hospitals, restaurants and cafés. Cigarette advertising is also banned. Attitudes 
towards smoking are changing, and its acceptability is declining. 
Fruit/vegetable consumption: 39% of men and 57% of women aged 16-64 years reported 
consuming the recommended 400g or more of fruit and vegetables daily. 3 
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Fruit and vegetable intake has increased steadily over the past 20 years, although consumption 
amongst teenagers is falling.  
Energy from fat: 36% of energy in the diets of adults (19–64 years) came from fat in 1997 
(more recent data is not available).4 
The proportion of daily energy from fat is a problem. Like other the Nordic countries, foods 
high in fat, such as pork, comprise a large part of the Estonian diet. However, consumption of 
saturated fats is decreasing, while the use of olive oil has increased notably as people move 
towards a more Mediterranean diet.  
Physical activity: 14% of both men and women aged 16–64 engage in at least 30 minutes of 
exercise in leisure time 4 times or more per week a week; 36% of men and 31% of women 
report doing so ‘a few times a year or never’. 2 
Physical activity is low in the population, but there is a social gradient: physical activity has 
increased among educated people, while disadvantaged groups are more likely to be 
sedentary. While the number of sports parks and swimming pools is increasing, these are used 
only by a proportion of the population. 
Overweight/obesity: 39% of men and 26% of women aged 16–64 years are overweight (BMI 
25–29.9kg/m2), while an additional 18% of both men and women are obese (BMI ≥30kg/m2). 2 
Blood pressure & cholesterol: Current data is not available. 
4. Status of the 4th JTF Guidelines 
The Estonian cardiovascular prevention guidelines were published in 2006. 5 They were based 
mainly on the European guidelines (of the 3rd JTF) but also incorporate material from other 
guidelines – British, American and Australian – that was considered important in the context 
of Estonia. In particular, the Estonian guidelines include a chapter on cardiovascular 
prevention in childhood. 
The guidelines have been published as a supplement in the most widely distributed national 
medical journal, Estonian Physician (Eesti Arst). The Estonian Society of Cardiology believed 
that this was the most effective means of reaching the whole medical community, including 
general practitioners and medical specialists other than cardiologists. It also generated a 
certain amount of public interest and discussion in journals. Following publication, the 
guidelines were presented at the biennial meeting of the Epidemiology and Prevention 
Working Group of the Society of Cardiology, and at the Society’s annual meeting. The 
guidelines are also available on the websites of the Society of Cardiology and the EHIF.  
The pocket version of the 4th JTF guidelines has been translated into Estonian and sent to the 
most important target groups – general practitioners, cardiologists, and internal medicine 
specialists – and distributed at meetings of the national neurology and endocrinology 
societies.  
Once the 2006 Estonian guidelines were published, the guideline development group decided 
not repeat the process again to further update the guidelines, as development had been a 
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time-consuming and demanding process. Instead, since the national guidelines adhered 
closely to the ESC guidelines and since the alliance was satisfied with those guidelines, it was 
decided to use the next ESC guidelines (of the 5th JTF) as national guidelines and to focus on 
developing a section on implementation to append to them.  
Multidisciplinary alliance 
A multidisciplinary group comprising key figures from relevant specialities including 
cardiologists, neurologists, GPs, internal medicine specialists, and paediatricians developed 
the Estonian guidelines. Each speciality took responsibility for a section. The inclusion of 
paediatricians to contribute a section on cardiovascular prevention in childhood was a 
distinctive feature of this guideline development group.  
Endorsement and implementation 
The EHIF finances the development of the main clinical guidelines and approves them as best 
practice for service providers. Once developed, the guidelines were discussed and agreed with 
the Fund, which seeks mainly to ensure that guidelines are evidence-based and can be 
supported financially by the Fund. Hence the guidelines are an agreed document about how 
cardiovascular prevention in Estonia should work. It was felt that agreement had been 
achieved smoothly and creatively, with beneficial cooperation on both sides. 
Once the Fund has approved guidelines, service providers are obliged to follow the guidelines 
according to contract, so that implementation is driven at least in part by the Fund’s 
endorsement and financial support. 
A precise plan for implementation is included as a section at the end of the guidelines 
document. This section outlines the  country’s prevention structure and describes how the 
guidelines are applied within this structure. It states the criteria for referral of patients from 
primary care to the cardiovascular prevention units; the information that should accompany a 
referral; the care that the patient will receive at the unit; and the long-term follow-up provided 
by the GP.  
SCORE 
GPs use the SCORE charts and if the risk calculation indicates that a patient is high risk 
(greater than 5% risk of mortality within 10 years), the patient might be referred to a 
cardiovascular prevention unit for diagnosis and treatment. 
Adherence and audit 
While there was no ongoing audit of guideline adherence, the Society of Cardiology together 
with the National Audit Office are at present performing an audit of how well GPs are 
following up with hypertension patients and screening for cardiovascular risk factors. The 
audit will examine whether patients’ risk is being calculated using SCORE and whether the GP 
has referred high-risk patients to the cardiovascular prevention units. GPs were asked to send 
all the relevant data on patients over the period of one year. The audit was due to begin by the 
end of October 2010.  
Adherence to the guidelines is to some extent compelled by the EHIF as prevention activities 
must be based on the guidelines, otherwise the Fund is not obliged to support these activities. 
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The Fund uses different mechanisms to monitor whether the guidelines are being followed. Its 
main tool is the clinical audit, which the Fund can order, and the resulting audit report can 
then be used to guide improvement in applying the guidelines in clinical practice. The Fund 
may also refer to its own database to examine discrepancies between health-care providers in 
diagnosis and treatment approaches. At the Fund’s regional offices, patient records can be 
examined to evaluate whether services are provided according to the service provider contract. 
It is accepted that in certain cases deviation from the guideline is necessary, but the Fund 
requires that the reason for the deviation is documented.  
Payment of physicians for prevention 
Since 2006, a performance bonus system has been implemented in general practices to 
incentivise physicians to achieve specified targets in key areas of health care. Points are 
awarded to GPs for performing specified activities, and those who achieve the required 
number of points receive a bonus for the year. The system covers the follow-up and 
monitoring of patients with chronic cardiovascular diseases, including patients with 
hypertension and diabetes and those who have had a myocardial infarction. The system also 
rewards physicians for engaging in activities directed at the prevention of cardiovascular 
disease. By 2008, 80% of GPs were participating in the bonus system.  
Screening 
Stimulated by the performance bonus system, active screening CVD risk in general practices is 
in operation in Estonia. Screening is partly opportunistic – any patient visiting a general 
practice will also have their  blood pressure and cholesterol checked and their cardiovascular 
risk assessed. Practices also invite registered patients to attend for screening. The general 
public has responded well, but it is acknowledged that screening is not reaching everyone.  
In addition, a system of the preventive check-ups up to age 19 is approved by the regulation of 
Minister of Social Affairs. GPs invite parents to bring their children to clinics for screening so 
that risk factors may be tackled starting from childhood.  
Prevention support services 
There is a network of about 20 smoking cessation offices across Estonia that are financed from 
the national cardiovascular disease prevention strategy. Thus funding comes from the State  
budget via the National Institute for Health Development, not from the EHIF. Members of the 
public can request a consultation to talk to a pulmonologist specialising in smoking cessation. 
The programme has been in operation for several years; however, the number of patients 
participating remains relatively low.  
5. Successes 
Improvements in CVD health 
While Estonia has one of the highest rates of cardiovascular mortality in Europe, the situation 
was seen as improving. Health behaviour and nutrition studies indicate that the risk factors 
are improving, albeit at a gradual pace. Recognition by the government of the need to tackle 
cardiovascular disease has been key to progress. In addition, the adoption of an intersectoral 
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approach has focused and improved the organisation of government strategy, and so 
ministries such as those of agriculture, education and culture (including sports) are working 
with the Ministry of Social Affairs in developing and implementing cardiovascular prevention 
strategy. The Ministry established a heart health strategy to run from 2005 to 2020, which has 
specific targets for reducing cardiovascular risk and mortality and for screening of people at 
high risk.5 
The population is increasingly better informed about cardiovascular disease and its 
prevention. However, there is socioeconomic variation and groups of lower socioeconomic 
status are less well informed and less oriented towards improving their health.  
Estonia has copied strategies used in Finland to tackle cardiovascular disease as the two 
populations are genetically similar and share similar dietary habits. In Finland, mortality has 
decreased in the population under 65 years by almost 80% in the past two decades, while in 
Estonia it has fallen by more than 20%.  
Prevention infrastructure 
A network of cardiovascular prevention units was established 10 years ago, with one unit in 
each of Estonia’s 15 districts. Each unit is staffed by cardiologists and cardiovascular nurses, 
and in some cases by internal medicine specialists. The units care for high-risk patients 
referred by general practitioners as well as dealing with aspects of secondary prevention.  
6. Challenges 
Premature mortality 
It was noted that the incidence of myocardial infarction among men aged between 30 and 50 
years is still high in Estonia, compared with other European countries. The death rate from 
coronary heart disease in men aged 64 years and younger was 104 per 100,000 in 2005, 
compared to 33 per 100,000 and 44 per 100,000 in Germany and the United Kingdom 
respectively in 2004. 7 
The Russian-speaking population 
Around a quarter of the Estonian population is Russian-speaking and reaching this 
community with cardiovascular prevention campaigns is a particular problem. Although 
health information is published in Russian as well as Estonian, the Russian community is more 
oriented towards Moscow and St Petersburg, including availing of Russian media, which 
carries little health promotion. Involving this group in prevention endeavours remains a 
challenge. 
7. Advice for 5th Joint Task Force 
Overall, it was felt that the ESC guidelines are a strong set of guidelines.  
It was acknowledged that while the guidelines are in danger of becoming too long, they would 
be enhanced if they included a section on cardiovascular prevention in children.  
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As the ESC’s aim is to promote use of the guidelines and to distribute them to all professionals 
involved in cardiovascular prevention, it was felt that the pocket guidelines should be free on 
the ESC website. And because the pocket guidelines are useful for GPs, it would be a good idea 
to find a means by which GPs could be informed by e-mail of the availability of the pocket 
guidelines online. 
More emphasis should be placed on implementation in the guidelines; otherwise they remain 
theoretical and do not influence or change practice. Intersectoral cooperation in 
implementation should receive more attention as improving lifestyles occurs in the broader 
context of society, not just in the health sector.   
More evaluation of implementation should be carried out to see whether adherence to 
guidelines really gives results. It was felt that the ESC should give more help to national 
societies to develop a methodology for auditing implementation. 
The need to do more to motivate primary health care providers to engage in prevention was 
mentioned, as was the effectiveness of payment as a motivator. 
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France 
1. Interviewees 
National coordinator Prof. Daniel Thomas 
Cardiac society Prof. Olivier Dubourg, coordinator of the guidelines committee 
of the French Society of Cardiology 
Heart foundation Prof. Daniel Thomas, former president of the French Federation 
of Cardiology 
Consultation Gaps 
 Health ministry: We were unsuccessful in securing the agreement of a representative of the 
health ministry to participate. 
2. Health system 
France has a public health system based on compulsory social insurance complemented by 
elements of tax-based financing and voluntary health insurance. The system is regulated by 
the state and the statutory health insurance funds. The national health insurance system 
comprises three schemes: a general scheme covering employees and their families (89% of the 
population); an agricultural scheme that covers farmers and their families; and a scheme 
covering self-employed people. The Haut Conseil de la Santé Publique (HCSP), which is 
integrated into the Ministry of Health, has a major role in decision-making in public health 
policy and programme implementation. 1 
3. Cardiovascular risk factors in the population 
Smoking: 36% of men and 28% of women aged 15–85 years are smokers (both daily and 
occasional). 30% of men and 24% of women are daily smokers.2 A decree banning smoking in 
public places came into force in 2007-08 and is considered to be a success. In September 2010, 
the HCSP issued an opinion on advancing the fight against tobacco with recommendations on 
political decisions in this area.3 
Fruit/vegetable consumption: 43% of the population consumes at least 400g of fruit or 
vegetables per day.4 
Energy from fat: 37% of average daily energy (excluding alcohol) is derived from fat for both 
men and women.4 
Physical activity: 64% of men and 63% of women practise at least 30 minutes of physical 
activity of moderate intensity at least 5 days per week.4 
Overweight/obesity:  41% of men and 24% of women are overweight (BMI 25-29.2kg/m2); an 
additional 16% of men and 18% women are obese (BMI ≥30kg/m2).4 
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Blood pressure: 34% of men and 29% of women between the ages of 18 and 74 years have 
hypertension (defined as SBP ≥ 140mmHg and/or DBP ≥ 90mmHg or being treated for 
hypertension). 4 
Cholesterol: 51% of men and 38% of women have dyslipidaemia (defined as triglycerides ≥ 
1.7 mmol/l and/or LDL ≥ 4.1 mmol/l and/or HDL ≤ 1.0 mmol/l and/or treatment with lipid-
lowering drugs). 4 
4. Priorities 
The Programme National Nutrition Santé (PNNS) (National Nutrition Health Programme), 
was launched in 2001 with the aim of improving the general health of the population through 
better nutrition. The first phase ran until 2005 and a second phase (PNNS 2) ran from 2006 to 
2010. The programme set 9 nutritional goals, 5 of which were related to diet (fruit and 
vegetables, calcium and vitamin D, fat intake, carbohydrate and fibre, and alcohol), 1 
concerned daily physical activity, and 3 involved nutritional markers (serum cholesterol, BP, 
and BMI). The PNNS is considered to be an exceptionally well-designed and well-
implemented strategy both in France and among international experts. The programme has 
been extended for a second time, and PNNS 3 will run from 2011 to 2015. Its objectives and 
strategy will be developed in close collaboration with the obesity strategy, which was launched 
in 2010. 
5. Status of the 4th JTF Guidelines 
The guidelines committee of the French Society of Cardiology (FSC) has endorsed the 4th JTF 
guidelines and translated them as part of its translation of the 2008 ESC Guidelines 
Compendium. The guidelines committee included members of the FSC, representatives of the 
cardiologists’ union, a representative of the National College of Hospital Cardiologists, and a 
representative of the Haute Autorité de Santé (HAS) (National Authority for Health). 
Publication was sponsored by MSD/Schering-Plough, and the compendium was sent to all 
cardiologists in France but not to other practitioners. The FSC is committed to endorsing ESC 
guidelines and avoiding duplication of guidelines already issued by the ESC. 
SCORE 
SCORE is not promoted by the FSC. Much opposition to its use was expressed by other 
professional societies when SCORE was initially launched in 2003, and the society decided not 
to pursue its implementation. An updated risk calculation tool for use in primary care based 
on a new Framingham model has been developed and a French version has been published.  
Other guidelines 
National guidelines on cardiovascular prevention have been developed by the HAS, which is 
an independent public body that reports to government. The national guidelines lead on 
treatment; physicians are obliged to adhere to the French recommendations because 
thresholds set in these guidelines are the basis for treatment reimbursements paid by the 
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health insurance funds. The French guidelines are issued as separate documents covering 
hypertension, obesity, smoking cessation, and so on. The national guidelines and the ESC 
guidelines are similar but as they are not issued concurrently, differences between them exist.  
The national guidelines are available on the website of the HAS; sending them to doctors 
individually would not be cost-effective. 
Adherence and audit 
No evaluation of the use of or adherence to the 4th JTF guidelines has been undertaken. 
Adherence to the national guidelines is assessed through the Evaluation of the Professional 
Practices (EPP), which is part of the continuing professional development that the HPST law 
of 2009 obliges health professionals to undertake. The objective of EPP is to measure the gap 
between observed practice and ‘ideal’ practice (i.e., that which adheres to the guidelines), with 
the aim of improving the quality of care provided to patients. EPP is carried out by doctors 
individually or in groups by the scientific societies registered with the HAS. EPP contributes 
100 of the 250 credits required by the HAS to validate a medical practice.  
Screening 
While there is no national programme to screen for cardiovascular risk, the general scheme of 
the national insurance fund (covering 89% of the population) launched a cardiovascular 
prevention campaign for its members in the summer of 2010. Initially, men aged 35, 40 and 45 
years and women aged 45, 50 and 55 years who do not already have a long-term illness have 
been contacted by post with information on cardiovascular risk and how to reduce it. A 
second mailing will contact older men (50–65 years) and women (60–75 years) when they are 
reimbursed for having their cholesterol measured (this does not include members who are 
already receiving cholesterol treatment) with the same information. The programme will 
contact in the region of 2,300,000 people each year.  
The French Federation of Cardiology worked with the insurance fund to put together the 
documents that were used in the mail-out to members. Documentation on treatment was also 
distributed to 30,000 GPs and 5,000 cardiologists. This documentation provided advice on 
how to deal with each risk factor and included the SCORE charts for use in assessing the 
cardiovascular risk of participants in the programme. 
Doctors are not paid for participating in the programme; the view was expressed that such 
payment would not be well regarded in France.  
Incentivisation 
Doctors are not paid for prevention. They have asked for many years that consultations for 
prevention be paid at a higher rate, as these consultations are of longer duration than other 
types of consultation. The recent HPST law makes provision for the ‘therapeutic education’ of 
patients, which would involve teaching patients with chronic illness how to manage their 
illness. As therapeutic education would be more time-consuming than a usual consultation, it 
is hoped that it will be paid differently. 
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Support services 
Provision of smoking cessation assistance was thought to be insufficient. For a person who has 
decided to quit smoking, an appointment with a practitioner specialised in tobacco cessation 
might not be available for some weeks or months. A helpline to assist in smoking cessation is 
operational, and national insurance will reimburse a patient for nicotine replacement therapy 
by €50 per year; this is not considered to be sufficient for effective treatment.  
6. Successes 
Salt in bread has been substantially reduced over the past 10 years, despite much resistance 
from bread-makers. The decrease has not been widely publicised as the public might not 
respond positively to it. 
The ban on smoking in public places has been implemented strictly. Its impact on hospital 
admissions for myocardial infarction was not as evident as in other countries and was 
statistically non-significant, probably because a less restrictive law in this area (Evin's Law of 
1991) was already in operation, which may have largely protected the population of non-
smokers. 
7. Challenges 
Industry interests 
Lack of political will is a substantial barrier to efforts to reduce the prevalence of smoking. It 
was felt that the government actually supports smoking because of the revenue it gathers from 
taxing tobacco sales. If the government increases the price of tobacco, it does not raise it so 
high that smokers give up the habit. Key officials in government are not easily accessible to 
anti-smoking groups, while figures associated with the tobacco industry are in the parliament 
and act as advisors to government.  
It has also been a struggle to improve public nutrition as the food industry has resisted any 
curbs on its freedom to operate – for example, reducing the amount of salt in bread, banning 
the sale of junk food in schools, or banning food advertising aimed at young children. Doubt 
was expressed over the value of food labelling and whether it has improved the public’s 
understanding of what it consumes. For example, labels include an objective statement about 
the need to have a healthy diet and to be physically active, but people interpret it as an 
endorsement of the health value of the product.  
Physician and patient beliefs 
Neither doctors nor the general public regard prevention as a priority as France has the lowest 
death rate for cardiovascular disease in Europe. Doctors are practising with a belief in ‘the 
French paradox’ – that despite high intake of saturated fat and red wine, coronary heart 
disease mortality rates are low. However, the existence of a French paradox was disputed and 
it was asserted that France reflects the risk gradient of Europe, with high risk in the north and 
low risk in the south. In Strasbourg and Lille, for example, in the north of France, diets are 
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rich in saturated fats, and CVD risk is on a par with Germany and Belgium. The point was 
made that anyone with risk factors in France is at the same risk as people in other countries.  
Doctors are also not inclined to tackle smoking in patients. While some GPs are taking greater 
interest in actively encouraging patients to quit, most assume patients are already aware of the 
dangers associated with smoking and do not use the tools available to assist patients in 
overcoming their addiction. Cardiologists were thought to be even less effective than GPs. It 
was felt that doctors avoid treating smoking as they are often unsure about how best to tackle 
it. They may also be concerned of the amount of time it will take and the costs involved. If the 
issue arises with a patient, most doctors send the patient to a specialist on smoking cessation.  
The view was expressed that in general cardiologists across Europe have little interest in 
tobacco. This was evident in the very limited space given at the 2010 ESC congress in 
Stockholm to tobacco. The congress included just one symposium and one session on tobacco 
and twenty posters among almost 6,000 communications. The neglect of smoking by 
cardiologists was attributed in part to the fact that their practice in prevention is very 
dependent on pharmaceutical-based research, with intensive study and pharmacological 
solutions for lipids and hypertension, so cardiologists manage these risk factors rigorously.  
Guidelines 
It was thought that the guidelines are too long for GPs. They manage several conditions and 
many medications, and it would not be appropriate for them to refer to the many  guideline 
manuals during consultations. Guidelines should be simple and easy-to-hand in a GP’s office.  
It was also thought that GPs in general did not know the guideline recommendations very 
well, and that the knowledge of many cardiologists was also incomplete. Hospital doctors 
were seen to have better opportunities to become familiar with the latest guidelines because 
they may be involved in education of juniors, A simple form of presentation was seen as useful 
to  assist GPs in getting familiar with guidelines.  
Costs of dissemination 
The FSC has been unable to disseminate a translation of the 2010 ESC Guidelines 
Compendium due to the production costs involved. The sponsor of the 2008 edition was a 
pharmaceutical company. The FSC felt that it was essential to make the 2010 compendium 
available, but the issue of funding translation and printing was a major hindrance and remains 
unresolved. It was felt strongly that the ESC should provide more support to cover these costs.  
SCORE 
The SCORE risk calculator was seen to be difficult to use in practice for several reasons: 
 Informing patients of their risk of dying is insensitive and ineffective in assisting to 
reduce their risk. People do not react well to such information; they go to their doctor 
to be reassured, not to be made anxious. 
 It is not valid for the individual patient; it is valid only as a population estimate.  
 In general, it overestimates risk for the French population, while at the same time 
underestimating risk for certain groups – for example, women under 50 years with 
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several risk factors. Doctors are aware of these anomalies and would feel dishonest to 
give patients risk scores if they themselves did not believe the scores. 
 It does not work for younger patients with multiple risk factors, and the suggestion of 
projecting the risk to age 60 is not a persuasive technique. 
 It refers only to death and does not include cardiovascular events, so the risk is quite 
low. The Framingham scale is more useful as it covers both morbidity and mortality.  
It was felt that SCORE was at best a useful tool in teaching students to help them visualise the 
risk in patients. 
8. Advice for the 5th Joint Task Force 
It was felt that the most important aim with new guidelines was to produce a very simple 
document for both GPs and specialists.  
It was also felt the guidelines must give more weight to smoking cessation and smoking 
prevention. The first guideline recommendation should concern smoking, noting that it is the 
risk factor that kills at lower ages, and in order to save the lives of younger people, physicians 
have to be interested in fighting tobacco and practise smoking cessation. The guidelines must 
explain precisely how to manage a smoker and outline different methods for approaching 
smoking cessation.  
It was suggested that the ESC should provide more support to national cardiac societies for 
the translation and printing of guidelines, as these costs mount year by year. In addition, the 
latest pocket guidelines should be available for free on the ESC website once a certain period 
of time had elapsed. 
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Germany 
1. Interviewees 
National coordinator Prof. Helmut Gohlke 
Prof. Ulrich Keil 
Cardiac society Prof. Helmut Gohlke, chairman of the Task Force on Prevention, 
German Cardiac Society 
Heart foundation Prof. Helmut Gohlke, board member of the German Heart 
Foundation 
Consultation Gaps 
 Health ministry: The Federal Ministry of Health felt that it would not be appropriate for it 
to speak on behalf of the country as a whole as competence is heavily devolved. The 
Ministry referred us to the Germany Cardiac Society. 
2. Health system 
The German health system is based on social insurance. The great majority of people (close to 
90%) are covered by statutory health insurance; the remainder are covered by government 
schemes (Beihilfe) and/or by private health insurance. Health care is decentralised and 
delegated to physicians’ and dentists’ associations and health insurance funds. Nearly 300 
insurance funds collect premiums and pay health care providers. The Ministry of Health is 
responsible for defining the framework of the health insurance system, supervising insurers 
and the professional associations and providing information. 1 
3. Cardiovascular risk factors in the population 
Smoking: 31% of men and 21% of women aged 15 and over are smokers.2 
Fruit/vegetable consumption: Current data is not available. It was noted that fruit and 
vegetable consumption is on the increase, but a clear social gradient is evident in 
consumption patterns. 
Energy from fat: Current data is not available. 
Physical activity: 22% of men and 20% of women aged 18 years and over engage in physical 
activity at least 5 times a week for at least 30 minutes.3 Exercise is compulsory in schools; at 
least 2 hours a week must be allotted.  
Overweight/obesity: 43% men and 29% of women aged 18 years and over are overweight 
(BMI 25-29.2kg/m2); 16% and 16% respectively are obese (BMI ≥30kg/m2).4 
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Obesity levels are high and rising in children and young people. Large differences are evident 
between the eastern and the western states, with higher levels in the states of the east, the 
former GDR. These differences were attributed to differences in diet.  
Blood pressure & cholesterol: Current data on the prevalence of raised blood pressure and 
cholesterol in the population is not available. The German National Health Interview and 
Examination Survey was lasted conducted in 1998,4 and updated data will not be available 
until 2012. The 1998 survey indicated high prevalence of hypertension (50% of men and 42% of 
women), and it was noted that this figure is incompatible with the country’s relatively low 
stroke mortality.  
4. Status of the 4th JTF Guidelines 
The German Guideline on Risk-adjusted Prevention of Heart and Circulatory Diseases,5 
published in 2007 by the German Cardiac Society (DGK), is based on the 3rd JTF guidelines, the 
2006 American Heart Association guideline on secondary prevention, and existing DGK 
guidelines on primary and secondary prevention. A pocket version was also published in 
booklet form. The German guideline is structured somewhat differently from the ESC 
guidelines but discrepancies in content are few. The main difference is that the German 
guideline includes explicit recommendations for policy-makers and medical practitioners on 
reducing the prevalence of each risk factor.  
The guidelines were disseminated through the medical community by the relevant specialist 
groups, but particularly by the DGK and the German Society for Cardiovascular Prevention 
and Rehabilitation. Summary versions of the guidelines have been reproduced in national 
scientific journals. 
Multidisciplinary alliance 
A task force on prevention developed the German guideline. The task force was established by 
the DGK to better co-ordinate prevention activities of the different scientific societies in 
Germany and to improve collaboration between them. The group includes the Hypertension 
League, the Lipid League, the German Heart Foundation, the DGK and the German Diabetes 
Society.  The work of the task force is ongoing and it meets several times a year to align the 
activities of the different member organisations.  
SCORE 
Two risk calculators for cardiovascular disease are used in Germany – SCORE Deutschland 
and PROCAM.  SCORE Deutschland is based on the ESC SCORE risk calculator and calibrated 
to German mortality data and health statistics as Germany falls in the middle of the high-risk 
and low-risk European countries. It was one of the first regional adaptations of the ESC 
SCORE and has been distributed widely in Germany. It has been published in the journal of 
the German Medical Association, Deutsches Ärzteblatt, which reaches more than 400,000 
physicians in Germany.6 
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Doubt was expressed about the quality of the data on which the PROCAM risk chart is based. 
It was suggested that the dataset for women was much too small to make  qualitatively 
acceptable estimates.  
Adherence and audit 
It was felt that the guidelines are adhered to in secondary prevention. However, no audit of 
guideline adherence on a national scale has been or is likely to be conducted. A representative 
audit would be a major endeavour and would require substantial funding. It was felt, however, 
that an audit should be conducted and, as it constitutes research into medical care, that it 
should be funded by the State. It was noted with some disapproval that research of this 
nature, such as EUROASPIRE, is typically funded by the pharmaceutical industry.  
It was suggested that findings from a study of guideline knowledge and perception of 
guidelines among physicians in the Münster region7 reflects the situation throughout 
Germany – that while physicians support the use of guidelines, many do not apply them in 
practice.  
A paper on risk factor changes in the Münster region based on the EUROASPIRE surveys from 
1995, 2000 and 2006 is being prepared for publication in 2011. This audit over 11 years has been 
undertaken in the context of a paper on the surveys published in the Lancet in 20098. The 
envisaged paper concentrates on the Münster region alone and will be much more detailed.  
Incentivisation 
Reimbursement of doctors for engaging in prevention activities is limited. Physicians treating 
hypertension and hyperlipidaemia are reimbursed by insurance companies. They are also paid 
for secondary prevention.  Smoking cessation treatment is only reimbursed, however, if the 
patient has COPD. In general, health insurance companies regard prevention as an individual 
responsibility and do not pay for it. 
Screening 
While it is part of the government’s health agenda that blood pressure, cholesterol, smoking 
status and so on should be checked, no structured screening programme for CVD has been 
implemented. Screening is opportunistic and not quality assured. There is also a lack of clarity 
over whether the patient pays for medications if diagnosed with raised blood pressure or 
cholesterol. 
5. Successes 
Cardiac rehabilitation 
Cardiac rehabilitation is strongly supported in Germany, and the entitlement to rehabilitation 
after a cardiovascular event has been legislated for. At one time residential rehabilitation was 
more or less mandatory for a patient after myocardial infarction; this requirement has been 
relaxed somewhat and ambulatory rehabilitation is gaining momentum. Some patients would 
rather avoid rehabilitation, however, because they are afraid of their job security if they are too 
long on sick leave.  
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Nutrition 
Life expectancy in eastern Germany, the former GDR, rose by 3.2 years within 7 years of 
reunification. This increase has been attributed to improvements in diet, especially increased 
consumption of fruit and vegetables. 8 
6. Challenges 
Political indifference 
The federal government has not played a role in developing or supporting the implementation 
of the guidelines and has not shown an interest in them. Scepticism was expressed about the 
government’s commitment to cardiovascular prevention. While it has formulated an agenda 
for prevention and the early detection of disease, it has not moved to realise this agenda in 
practice. It is felt that services in these areas could be much better structured than they are at 
present. It was noted that federal health ministry’s web page on prevention had not been 
updated since 2006 and that this reflected the government’s apathy.  
Competence for health strategies lies mainly with the ministries of health of the governments 
of the 16 federal Länder (states).These ministries of health have set goals (more or less clearly) 
to reduce cardiovascular mortality, although doubt was expressed about the degree to which 
the respective administrators were endeavouring to achieve these goals. 
Disillusion was expressed with the response of politicians to efforts by doctors and 
representative bodies to tackle risk factors such as smoking. It was felt that politicians do not 
really care about health and that they yield too readily to lobbying from business, for example 
in relation to smoking restrictions in bars and restaurant.  
Smoking 
While each of the federal states has implemented legislation restricting smoking in public 
places, the bans are not outright, except in Bavaria. There is evidence, however, that the public 
would support more stringent measures against smoking. In 2008, the government of Bavaria 
rolled back legislation that banned smoking in all public places, but (much to the surprise of 
politicians) the ban was reinstated following a referendum of the people in 2010. This was seen 
as an indication that the public is increasingly embracing the anti-smoking message. Similar 
referendums are planned in other states if politicians show themselves to be reluctant to 
change the law.  
The view was expressed that government is primarily interested in the taxes from tobacco 
consumption as it does not bear the cost – that falls to the insurance companies. It was also 
said that the tobacco lobby was strong and that there were connections between political 
parties and the tobacco companies. A smoking ban could have been implemented by the 
federal government as a law to protect workers, but the minister delegated the responsibility 
to the states. 
Inconsistency of approach 
It was noted that despite cooperation between the different scientific societies, there are 
differences of emphasis among them. For example, some societies will concentrate on the 
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single risk factor that is the focus of their society instead of the multifactorial risk evaluation 
approach advanced by the German Cardiac Society. 
7. Advice for the 5th Joint Task Force 
Satisfaction with the current German guidelines was expressed. The difficulty of keeping 
guidelines short and usable, while still comprehensive was acknowledged. Even pocket 
guidelines have a tendency to enlarge.  
It was suggested that the ESC guidelines might follow the example of the German guidelines 
and include a recommendation written for the politicians and policy-makers that describes 
the measures that need to be taken to reduce the risk associated with each risk factor.  
It was recommended that a stand-alone PC-based version of the regional SCORE Deutschland 
charts should be made available so that the software can be given to physicians to load onto 
their computers. This would mean that doctors would not be dependent on being able to go 
online. 
It was felt that the accessibility of HeartScore on the ESC website needs to be improved; at 
present, it takes considerable effort and clicking through to reach it.  
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Ireland 
1. Interviewees 
National coordinator Dr Siobhan Jennings 
Cardiac society Dr Declan Sugrue, president, Irish Cardiac Society 
Heart foundation Ms Bridget Caffrey-Armstrong, project manager for guideline 
implementation, Irish Heart Foundation 
Health ministry Dr John Devlin, deputy chief medical officer, Department of Health 
and Children 
Health service agency Dr Siobhan Jennings, consultant in public health medicine, Health 
Service Executive 
2. Health system 
Ireland’s health system is characterised by a mix of public and private services. The 
Department of Health and Children (DoHC)is responsible for health policy, while the Health 
Service Executive (HSE) delivers health services. The health service is predominantly tax-
funded, with approximately three-quarters of health spending coming from public sources. All 
residents are eligible for hospital services, but only those who hold a “medical card” (one-third 
of the population) receive both hospital and primary care services free of charge. Qualification 
for a medical card is largely related to (lower) income and (higher) age. Private health 
insurance plays an important role in the Irish health system. Individuals contribute to health 
insurance to be guaranteed more immediate access to some hospital interventions, with about 
half of the population opting to invest in such care. Approximately one quarter of the 
population has neither a medical card nor health insurance.1 
3. Cardiovascular risk factors in the population 
Smoking: 31% of men and 27% of women aged 18 years and over are current smokers.2 
Fruit/vegetable consumption: The mean number of servings of fruit and vegetables 
consumed daily is 7, equating to 560g; the level recommended by the WHO is 400g. 2 
Energy from fat: 36% of total energy comes from fat; the recommended maximum is 35%.2 
Physical activity: 55% of the population report being physically active, which was defined as 
taking part in exercise or sport 2-3 times per week for at least 20 minutes or engaging in more 
general activities, such as walking, 4-5 times per week for at least 30 minutes per day. 2 
Overweight/obesity: 39% of adults aged 18 years and over are classified as overweight (BMI 
25-29.2kg/m2), while 25% are classified as obese (BMI ≥30kg/m2). 2 
Blood pressure: 60% of adults aged 45 years and older have raised blood pressure 
(≥140mmHg SBP or ≥90mmHg DBP). 2 
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Cholesterol: 82% of the population aged 45 years and over have raised cholesterol (total 
cholesterol ≥5.0mmol/L). 2 
4. Priorities 
Smoking reduction is the main priority related to cardiovascular disease prevention for the 
DoHC, and it aims to release a new anti-tobacco strategy that focuses on pricing and 
interventions at the end of 2010. Alcohol misuse (along with substance abuse) is a second 
priority area. 
National guidelines on physical activity have been published3, and there is recognition of the 
need for an intersectoral approach to such strategies. For example, the physical activity 
strategy must involve the Department of Transport and the development of transport policy 
that promotes walking and cycling.  
It is acknowledged that more work must be done on obesity. The National Taskforce on 
Obesity issued recommendations in 2005 aimed at tackling the obesity epidemic,3  and it is 
hoped that a national nutrition strategy, which is due to be published, will help to make 
progress on reducing levels of obesity. Salt intake is also a concern. A target to reduce intake 
by 16% over 4 years has been set in the national cardiovascular health policy 4. In support of 
this target, the HSE procures low-salt bread for use in its institutions. 
5. Status of the 4th JTF Guidelines 
At present, the use of cardiovascular prevention guidelines is quite fragmented in Ireland. 
While many doctors use the ESC guidelines and the SCORE charts (including HeartSCORE), 
use of the Joint British Societies’ guidelines, particularly the hypertension guidelines, is not 
uncommon. The American Heart Association guidelines are also used to a lesser extent, 
mainly among doctors and consultants who have trained or worked in the United States. 
Multidisciplinary alliance 
The National Coordinator for CVD Prevention was appointed in 2005 by the Irish Cardiac 
Society. In 2008 the Irish Heart Foundation (IHF) established a Council of Prevention, with 
the aim of taking action to have the 4th JTF Guidelines endorsed by the key stakeholders in 
cardiovascular disease prevention. The executive of the Council comprises the chair, the 
National Coordinators for Ireland and Northern Ireland, the chair of the Cardiovascular 
Health Policy Group, the guidelines implementation coordinator, and representatives of the 
IHF, the Stroke Council, the HSE, and the Irish Council of General Practitioners (ICGP).  The 
Council as a whole embraces stakeholder groups including schools, the different councils 
operating within the IHF (such as the Blood Pressure Council) and professional societies such 
as the Irish Endocrine Society and the Irish Nephrology Society. 
Endorsement and implementation 
The Irish Cardiac Society has endorsed the guidelines. As doctors have a statutory 
responsibility for continuous professional development, the Society regards it as the 
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professional duty of cardiologists to adhere to the guidelines issued by the ESC. The Society 
does not see itself as having a role in the wider implementation of the guidelines across the 
medical community as it is a small organisation with a limited remit and without the 
necessary funds for such an endeavour. 
The Irish College of General Practitioners (ICGP) has also endorsed the guidelines and has 
promoted use of the guidelines by different means: the publication of articles in its journal, 
Forum; publication of the SCORE charts in its diary and yearbook; and at its 4th Annual 
Summer School 2010 where HeartSCORE was presented to attendees.  
The national cardiovascular health policy, Changing Cardiovascular Health4, a 10-year plan 
which was launched in 2010, recommended that the guidelines be adopted. It also 
recommended that a care protocol for primary care based on the guidelines should be 
developed and that protocols on best practice in cardiovascular clinical care should be agreed. 
In addition, a national committee will be established under the DoHC’s new National 
Framework for Clinical Effectiveness – this is expected to oversee formal implementation of 
these, as well as many other guidelines in practice. 
While the 4th JTF guidelines have been adopted officially, the IHF Council on Prevention has 
decided to defer a project of actively promoting national uptake of the guidelines by 
practitioners until the 5th JTF Guidelines are available. A symposium was held in November 
2010 to bring together relevant stakeholder organisations to examine how the implementation 
of the guidelines might proceed and to identify any problems groups might have with using 
the guidelines.  
Distribution of the guidelines  
While the Irish Cardiac Society has not formally disseminated the guidelines to its members, it 
is confident that cardiologists are very well aware of them. Members have received the 
guidelines through the European Heart Journal, and guidelines are also discussed at the ESC 
annual meeting and at other conferences that members attend.  
The guidelines have not been disseminated by the IHF Council on Prevention to the rest of the 
medical community as it does not wish to pre-empt the process of endorsement. In addition, 
the Council feels that the guidelines are not presented in a way that is practical for application 
in consultations. The Council aims to adapt the ESC guidelines to a version that is more user-
friendly, for instance, for use in general practice consultations – ideally, one page that includes 
an algorithm and the SCORE charts. It is considering using a format similar to that used by 
the Irish Cancer Control Programme to guide general practitioners on the diagnosis and 
referral of breast cancer. The CCP with the ICGP has produced a double-sided, laminated A4 
page with an algorithm for diagnosis on one side and a referral page on the other side. A copy 
has been sent to every GP and the initiative has received positive feedback. 
SCORE  
At present there are no plans to develop an Irish version of SCORE. There is some concern 
with the implications of using the SCORE cut-off for high risk (5% risk of death from 
cardiovascular disease death in the subsequent 10 years). Doubt over the evidence base for the 
cut-off  point was expressed, as well as concern that it would be used automatically by general 
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practitioners as a starting point for medication where other treatment approaches might be 
more appropriate. The IHF Council on Prevention in early discussions considered conducting 
a health economics appraisal to evaluate appropriate thresholds for initiation of 
pharmacological treatment.  
Adherence and audit  
While there was general agreement that it is important to audit adherence to guidelines and 
that it was feasible to do so, no system to do so has been established. There was no sense of 
how much clinicians might adhere to the guidelines. It was noted that guidelines are not rules 
and that practising clinicians will do what they think is best for an individual patient. The 
point was also made that there is a certain amount of audit fatigue among clinicians, and the 
importance of carrying out scientifically sound and valid audits was emphasised.  
 The IHF Council on Prevention plans to conduct a baseline survey of GPs to assess the extent 
to which they are documenting risk factors, using a risk factor assessment tool and following 
up with patients identified as high risk. 
Once the guidelines are mandated as the national guidelines by the DoHC, another agency, 
the Health Information and Quality Authority (HIQA), becomes responsible for evaluating 
their implementation at different levels (primary care, hospitals and other institutions) in the 
public health system. Whether HIQA is responsible for auditing the private system is 
uncertain.  
6. Successes 
Benefits of guidelines 
The benefit of having guidelines and their contribution to improved quality of care for 
patients across a broad range of conditions is recognised. Guidelines are seen to be necessary 
in order to make sense of data and to apply the knowledge gained from evidence in practice. 
Progress in cardiovascular health 
 Premature mortality from cardiovascular disease has reduced markedly over the past 
decade. The pace of change in the decline of coronary heart disease mortality was found 
to have increased steeply from 1998.6 
 HeartWatch, a pilot programme for secondary prevention in primary care, was started in 
2000. It introduced the concept of structured care for secondary prevention into general 
practices and although demonstrated to be successful, was not extended for financial 
reasons.  
 Cardiac rehabilitation services, with trained coordinators, are available in every cardiac 
centre. However, the extensive service development seen between 1998 and 2005 (the 
period of the first cardiovascular strategy7) has slowed, with many services unable to 
provide programmes to all relevant cardiac groups (e.g. heart failure and peripheral 
arterial disease patients).  
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 Rapid progress has been made in stroke care, albeit from a very low base; the number of 
stroke units has increased from 1 in 2006 to 16 at present. 
 HeartBeat, an initiative to improve acute myocardial infarction care and reduce mortality 
in Irish hospitals, has resulted in over 90% of patients in 9 pilot hospitals receiving seven 
of eight key components of care, including secondary preventive medication/stroke 
therapy on discharge. 
 The introduction of the concept of Primary Care Trusts (PCTs) is helping to change the 
way medical professionals think about their practice and the populations they serve. 
7. Challenges 
Guideline fatigue, overload and inconsistency 
There is guideline fatigue amongst practitioners; most deal with multiple conditions and they 
feel overwhelmed with the number of guidelines they must follow.  The constant updating of 
guidelines is exasperating, although it is difficult to see how this might be avoided because the 
scientific evidence that underpins the guidelines inevitably changes. The lack of consensus 
between guidelines from the various learned societies is also frustrating. 
The 4th JTF guidelines were not thought to be user-friendly for working within patient 
consultations – because of their complexity, consultation within a physician-patient encounter 
was seen to disrupt the interpersonal  communication. 
Lack of ownership 
To some extent physicians feel a lack of ownership of the guidelines. However, it is accepted 
that this is hard to avoid as Ireland is a small country relative to Europe. It was acknowledged 
that the ESC tries to involve members in its work and that most clinicians wish to concentrate 
on treating patients rather than on committee work. 
Focus on prevention in Ireland 
A prevention focus is lacking in Irish health care at present; it is still focussed very much 
towards reacting to ill health. The DOHC  is conscious that prevention needs to be integral to 
primary care. A major step that is needed is to write a new general practitioner employment 
contract that would enable the development of prevention in primary care.  The DoHC has 
initiated that process but envisages that budgetary constraints in the current economic 
climate are going to pose difficulties to the endeavour. The DoHC is considering adopting an 
approach similar to that taken in England, i.e., setting targets around specific risk factors. 
Ireland is seen as performing moderately well in relation to prevention. It is felt that one of 
the challenges in cardiovascular disease prevention is that it is not firmly enough embedded at 
the front line among hospital cardiologists. In addition, it is felt that a divide exists between 
cardiologists and CVD prevention groups. To give prevention greater credibility, ownership of 
some aspects of prevention must be given to the clinicians. Consultant cardiologists whose 
formation and whose research track record is in part in prevention were seen as necessary. 
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However, the lack of clarity within the Irish health service over subspecialty needs and who 
decides on those needs is likely to prove a barrier to effecting such appointments. 
Smoking cessation support 
The provision of smoking cessation assistance is patchy. A study of services found that while 
services were available in all of the four HSE administrative areas, their reach was insufficient 
to provide an appropriate level of service to the target 5% of smokers per year. Some regions 
were particularly under-served and some counties had minimal or no access to service.8 
Monitoring outcomes 
Outcomes of care, such as 30-day AMI and ischaemic stroke case fatality rates, are not well 
monitored. Improved structures are required to audit hypertension, atrial fibrillation and 
hypercholesterolaemia. 
8. Advice for the 5th Joint Task Force 
The next version of the guidelines has to be simple, practical, and user-friendly so that they 
are easy to apply in practice. At the same time, it was acknowledged that a lot of 
cardiovascular care and management is not simple and that some guidelines users want to 
have all the evidence in one source and the guidelines provide that. 
Concern was raised about potential for bias in guideline committees, as decisions on some 
guidelines can have significant financial consequences for third parties. The problem arises 
less in relation to prevention guidelines, but there still is potential, for example, for 
pharmacological companies to influence guidelines to their benefit.  
It was suggested that guidelines should be developed in a format that is accessible and 
comprehensible to the general public – for example, a web-based, interactive tool that would 
give members of the public concrete feedback on their performance in reducing risk. It was 
proposed that a standard template might be developed by the ESC, which countries could 
modify to their specific needs. It was felt that patients and the public need to be encouraged to 
more aware of their risk and to take greater responsibility for reducing it. 
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Italy 
1. Interviewees 
National coordinator Dr Simona Giampaoli, director of research at the National Centre of 
Epidemiology, Surveillance and Health Promotion, Istituto Superiore 
di Sanità. 
Cardiac society Dr Giuseppe Di Pasquale, president of the Italian Federation of 
Cardiology 
Heart foundation Dr Lidia Rota, president of the Italian Association against Thrombosis 
and Cardiovascular Diseases (ALT) 
Dr Andrea Peracino, vice-president of the Italian Heart Association  
Consultation Gaps 
 Health ministry: No response to interview requests was received from the ministry. 
2. Health system 
Since the early 1990s, Italy’s health care system has devolved into a regionally based national 
health service (Servizio Sanitario Nazionale (SSN)). The national level is responsible for setting 
the general objectives and fundamental principles of the national health care system. The 
State has defined a basic package of health services that the SSN is required to provide 
uniformly in all regions. Regional governments, through the regional health departments, are 
responsible for ensuring the delivery of this benefits package through a network of 
population-based health management organisations (azienda sanitaria locale (ASLs)) and 
public and private accredited hospitals. The SSN provides universal coverage free of charge at 
the point of service. Health care is mainly financed by central and regional taxes.1 
3. Cardiovascular risk factors in the population 
Smoking: 23% of men and 20% of women aged 35-79 years are current smokers. Legislation 
banning smoking in public places was adopted in 2005. 2 
Fruit/vegetable consumption: The median intake of fruit and vegetables among a sample of 
participants aged 20–70 years in the EPIC study was 500g per day.3 
Energy from fat: No data available. 
Physical activity: 34% of men and 45% of women aged 35-79 years do not engage in any 
physical activity in their leisure time. 2 
Overweight/obesity:  48% of men and 34% of women aged 35-79 years are classified as 
overweight (BMI 25-29.2kg/m2), while 25% of men and 27% of women are obese (BMI 
≥30kg/m2). 2 
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Blood pressure: 55% of men and 42% of women aged 35-39 years have hypertension (defined 
as SBP ≥ 140mmHg or DBP  ≥ 90mmHg or being treated for hypertension).2 
Cholesterol:46% of men and 52% of women aged 35-79 years have hypercholesterolaemia 
(defined as total cholesterol ≥200mg/dl or being treated for hypercholesterolaemia). 2 
The major cardiovascular risks in Italy are obesity and smoking. Control of hypertension and 
cholesterol levels has improved significantly in the past 10 to 20 years. While smoking 
restrictions have been successful among adults, they have not had an impact on smoking 
among children and young people. 
4. Priorities 
National prevention plan 
A National Prevention Plan 2009–2012 is in place, in which one area of action is the prevention 
of cardiovascular disease (including diabetes and obesity). The plan emphasises the 
identification of the high-risk population and the use of technology in diagnosis. It gives 
greater attention to the secondary prevention and the recurrence of events than to primary 
prevention. One of the aims of the plan is to maintain the low-risk population at low risk 
during life and to increase the proportion of the population at low risk. A second is to identify 
and address people at high risk or with metabolic syndrome.  
Since June 2010 regions have been producing their own regional strategies for the 
implementation of the national prevention plan based on guidance from the ministry of 
health. However, this process will take time as existing projects cannot be overhauled quickly. 
As regions are autonomous, each region can take its own approach and develop its own 
projects to implement the plan. 
The Gaining Health (Guadagnare Salute) programme has as its main objective to prevent and 
change harmful behaviours that are the main risk factors for common non-communicable 
diseases. Four areas in which to concentrate endeavours have been identified: the promotion 
of healthy eating; tobacco control; combating the abuse of alcohol; and the promotion of 
physical activity. 
5. Status of the 4th JTF Guidelines 
In 2008 the Italian Federation of Cardiology translated the executive summary of the 4th JTF 
guidelines and published it in the federation’s national journal, the Italian Journal of 
Cardiology. An editorial commentary by national cardiovascular experts including 
recommendations was published alongside the translation.4 The main adaptation of the 
guidelines to the Italian context was the adoption of a specific Italian risk estimation tool 
instead of the SCORE chart. The federation’s policy is to adhere to ESC guidelines on 
myocardial infarction, heart failure, prevention and so on, and not to produce additional 
Italian guidelines in cardiology. The federation has approximately 10,000 members who have 
received the translation of the guidelines through the journal. The guidelines are available on 
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the federation’s website, while the English version is available on the website of the Italian 
Association for Cardiovascular Rehabilitation and Prevention (IACPR). 
Different approaches have been taken in different regions to disseminating the guidelines. For 
instance, some regions, such as Emilia-Romagna and Lombardy, have a prevention committee 
that operates a number of initiatives for specialists and GPs, including the implementation of 
the Italian risk chart. In relation to that, a number of educational meetings have been held 
where the ESC guidelines have been presented. There is likely to be variation in approach 
across regions, however, as each is autonomous and some regions have not established a 
similar organisation to that of Emilia-Romagna.  
Multidisciplinary alliance 
While the Italian version of the guidelines was produced in close consultation with the various 
cardiovascular societies, no alliance for the implementation of the guidelines has been 
established. Implementation occurs through the endeavours of the professional societies and 
the ASLs and alongside the implementation of the Italian risk chart through Progetto CUORE 
(described below).  
Other guidelines 
The Italian national guidelines on stroke treatment and prevention have been developed by 
SPREAD (Stroke Prevention and Educational Awareness Diffusion), an interdisciplinary group 
of 36 professional societies and 2 patient groups in Italy. These guidelines incorporate the ESC 
guidelines. It was felt that this multidisciplinary group is an effective means of implementing 
guidelines in relation to stroke. Equivalent national guidelines for other cardiovascular 
diseases have not been developed in this way. 
Risk assessment  
Cardiovascular risk assessment was recommended in the National Prevention Plan 2005-2009 
as the first step to implement preventive actions at individual level.  A means of assessing risk 
in the Italian population was developed by the Istituto Superiore di Sanità (ISS) as part of the 
Progetto CUORE, a major project to monitor the epidemiology of cardiovascular disease and 
to undertake its prevention in Italy. The CUORE score is based on data from longitudinal 
studies carried out on population groups followed up over time. Two tools for the estimation 
of global absolute cardiovascular risk have been developed: cardiovascular risk charts and 
individual scores. The two instruments differ in how risk factors are used, the number of 
factors considered and the way in which risk is expressed. Doctors can download the software 
to calculate individual scores from the Progetto CUORE website. The CUORE score predicts 
10-year risk of fatal and non-fatal coronary and cerebrovascular events; in terms of its 
prediction of fatal events, it is very similar to the risk assessment of SCORE for low-risk 
European countries. 5 
Within the framework of the National Prevention Plan, a national training programme on risk 
assessment for GPs was launched and the programme was offered to the regions. The training 
programme is organised in 5 packages: 2 residential packages, one on the use of the global 
absolute cardiovascular risk chart and the other on risk communication, promotion of healthy 
life styles and pharmacological treatment; 1 self-training package, on risk assessment of 
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patients and collection of data (risk factors and risk scores) by GPs; and 2 workshops for the 
discussion of the data collected. The training programme is CME credited.   
Adherence and audit 
Guideline adherence across the country is not monitored directly and doing so would be 
difficult because of the regionalised nature of the Italian health system. It is felt that in general 
doctors are not assessing patients’ cardiovascular risk. 
Screening: Progetto CUORE 
Cardiovascular prevention by the state is conducted in large part through the Progetto 
CUORE, which is an element of the National Prevention Plan of the Centro Nazionale per la 
Prevenzione e il Controllo delle Malattie (CCM) and coordinated by the ISS. Initiated in 1998, it 
comprises four elements: 
 large-scale longitudinal studies of risk factors in the population with follow-up on fatal 
and non-fatal cardiovascular events 
 training of GPs in cardiovascular risk assessment and use of the risk charts 
 the establishment of a registry of coronary and cerebrovascular events 
 participation in the European Health Examination Survey (EHES) of risk factors in the 
population. 
One of the research lines of the project is the Cardiovascular Risk Observatory (CRO), which 
monitors the use of risk assessment in clinical practice. The data collected will be used to 
assess effectiveness of risk assessment application in clinical practice and may be used as a 
tool for decision support at both national and local level.  
The project includes a screening component at primary care level involving the voluntary 
participation of GPs. GPs are encouraged to collect data on risk factors and 10-year 
cardiovascular risk in patients aged 35–79 years. This is seen as a first step in implementing 
primary prevention at the individual level in clinical practice. Screening has been 
implemented in different regions. The basis for selecting patients for screening varies – in 
some regions, a day is allocated to measuring risk, in others it is opportunistic when a patient 
attends for an unrelated reason, in some cases GPs will measure risk only if a patient has a 
prescription for statins. 
The risk assessment software supports GPs in prevention activities, enabling them, for 
example, to print out patients’ risk scores, with recommendations for lifestyle and therapy. 
GPs may also manipulate the data – for example, to compare a patient’s risk with that of a 
person having desirable levels of all modifiable risk factors. The ability to set up a data archive 
and monitor cardiovascular risk trends of patients over time assists GPs to self-audit their 
performance in cardiovascular disease management. 
In some regions, such as Sicily, Basilicata and Molise, GPs participating in the programme are 
paid, not for measuring risk, but for sending in the data to the CRO. The project 
administrators try to avoid the suggestion that GPs are paid to measure risk because they feel 
this should be regarded by GPs as part of their work. In addition, the cost of statins is 
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reimbursed where there is no indication of family history when the 10-year risk assessment is 
>20%, based on the ISS charts. 
The activities of the project are not distributed uniformly throughout the country. The 
registries have been established in just a few regions, while the longitudinal studies derive 
samples from all regions. GP training and participation is variable across regions.  
Prevention services 
Smoking cessation services are widely available in Italy. A guide to services published in 2007 
listed 362 centres, over half of which were located in the north of the country.6 A survey of 
these services found that 22% were free to patients, the rest requiring some payment 
depending on the region and its health regulations.7 People can be referred through their 
doctor or they may access a service directly without referral. Doubt was expressed, however, 
over the extent to which smoking cessation support was offered in cardiac rehabilitation. 
6. Successes 
Risk factor control  
Data gathered from the CRO suggests that risk can be reduced and maintained at a low level 
in the population and that counselling may be well received by patients. While results are 
limited as the CRO is in the early stages of collecting data, they suggest an improvement in the 
control of hypertension and hypercholesterolaemia. 8 
7. Challenges 
Communication with the public 
It was felt that more focus on communicating with the public on prevention and especially 
lifestyle is needed. The efforts of the many people working diligently on prevention at a high 
level largely fail to trickle down to the ordinary person. The problems of smoking and obesity 
have been discussed repeatedly in the media, but this has not motivated people to change 
their lifestyle behaviours. It was felt that the message that people need to take responsibility 
for their health is not well received by the public and that people prefer to delegate to a doctor 
and be given a pill. 
The difficultly of reaching a population of 56 million and the costs involved was noted, as was 
the need to find a more effective means of conveying the prevention message so that the 
public responds – perhaps through television or the Web. For example, ALT developed a 
project about staying healthy in the workplace, which was implemented in two companies. 
Alitalia sent the project’s risk questionnaire to all members of their frequent flyer club and the 
response level was good. This represented a new approach to gaining public attention.  
Physician attitudes  
It was felt that implementation of guidelines will be impeded if individual practitioners are left 
to decide for themselves on the use of the risk charts and the guidelines, as health 
practitioners typically do not regard prevention as a priority. The point was made that Italian 
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medical training does little to orient future physicians towards prevention. Practitioners 
regard prevention as less challenging than treatment and hold the view that the role of a real 
doctor is to take care of sick people. It will be a long-term project to change physician 
perceptions, but it was thought that a start should be made.  
In addition, at present several health projects are running – for example, on diabetes, 
influenza vaccination, osteoarthritis and osteoporosis – and it is testing for GPs to keep 
abreast of all. In this context, they will only engage in risk assessment when they are 
convinced of its usefulness. The Progetto CUORE administrators emphasise that prevention 
concerns not just CVD but all chronic disease.  
Follow-up 
A big problem that the risk assessment programme has encountered is achieving active 
participation of patients in follow-up. Once a patient has been identified as being at risk, a GP 
needs to check their risk factors every year. However, it’s very difficult for GPs to organise that 
the patient returns.  
Pace of progress 
One of the challenges that the Progetto CUORE has encountered is the slow progress in 
training GPs. It started in 2005 and around 3500 out of 42,000 doctors have been trained to 
date. The slow progress is attributed to the elapse of relatively little time between the 
introduction of the programme and the agreement by GPs to participate in the surveillance 
system.  
Funding 
It was felt that despite the cardiovascular prevention being listed as a priority for health policy 
that it was not being funded by government at population level. 
Real-world context 
While guidelines were thought to be important, the degree to which they can be applied in a 
real-world context of a hospital ward or an emergency room was questioned. It was felt that 
guidelines are developed and discussed in an intellectual realm that is isolated from the world 
in which health practitioners practice. The contingencies of the real world make it difficult to 
apply the guidelines systematically, and guidelines can never achieve their goals as a result.  
In addition, it was mentioned there are methodological problems with measuring clinical risk 
factors in patients. The example of cholesterol was given, the measurement of which uses an 
imperfect marker and, as a consequence, raised cholesterol is missed in a substantial number 
of young people. 
It was noted too that patient adherence – with medication regimes, for example – has been 
found to be wanting, which undermines the intentions of guidelines. It was suggested that 
patients should sign an agreement when starting treatment to cooperate fully and comply 
with the requirements of the treatment.  
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Continuity of care 
The transition of patients with cardiovascular disease from hospital to GP care was thought to 
be poorly supported. Problems exist around the transfer of information to the GP or family. 
There is no electronic patient record, and the clinical record is sometimes incomplete when 
the patient is discharged because the hospital is still waiting on examination results, reports 
from pathology, x-ray, and so on. The consultant typically prepares a very short summary of 
the patient’s stay and gives it to the patient going home. Discharge conferences with 
consultant, GP and patient are rare, and many patients leave hospital without knowing the 
next steps in their treatment.  
8. Advice for the 5th Joint Task Force 
One view held that the current guidelines are satisfactory, and the main problem was to 
achieve adherence to the recommendations among both physicians and patients. Another 
view held that the guidelines are too long and too difficult to follow, for GPs in particular. A 
version developed for the specific needs of GPs was suggested, one that would provide the 
type of information that would convince them of the value of prevention – for example, that 
reducing weight by 10kg reduces mercury by 5-10mm, following the DASH diet reduces it by 8-
15mm, and reducing alcohol consumption leads to a reduction of 2-4mm of mercury. This is 
the type of information that many GPs have not been given. It was also suggested that 
guidelines for the public, describing the basic points in everyday language, should be 
developed.  
It was generally felt that the public needs to be bettered informed on their risk of 
cardiovascular disease and that all the risk factors need to be addressed. The young population 
in particular needs to be targeted in relation to overweight and smoking. Although obesity 
levels are relatively low in comparison with other European countries, they are increasing and 
especially amongst people under 20 years of age. 
It was felt that the guidelines should include a section dedicated to population-based 
recommendations in order to maintain people at low risk during their lives. The guidelines 
focus on high-risk patients, but they should also address prevention ever before people enter 
that category, while they are still healthy. It was also felt that lifestyle change needed to be 
stressed more strongly and that without this, concentrating on treatment will not have the 
desired results. Many heart patients feel that their problem is solved once they leave hospital, 
but that is not the case – they need to change their lifestyle to avoid future events.  
There was a proposal that the composition of the guideline development committee should be 
more open and that committee members who have been in their positions for quite a long 
time should be replaced by younger members. It is important to bring in younger people who 
are familiar with the practical, day-to-day aspects of working according to the guidelines. If 
guideline implementation has not been successful, responsibility for implementation should 
pass to a new generation.  
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The Netherlands 
1. Interviewees 
National coordinator Dr Roderik Kraaijenhagen 
Cardiac society Dr Roderik Kraaijenhagen, president of the committee of 
cardiovascular prevention and cardiac rehabilitation, Netherlands 
Society of Cardiology 
Heart foundation Dr Anne-Margreet Strijbis, project manager, Knowledge & 
Innovation Department, Netherlands Heart Foundation 
Health ministry Professor Marc Berg, lead advisor to the Ministry of Health on the 
reform of the funding structure for cardiovascular disease prevention 
and management 
Health service agency Dr Irene Hellemans, senior inspector for health care, Health Care 
Inspectorate 
 
2. Health system 
The health system in the Netherlands is funded by health insurance on three levels, each 
governed by different bodies. Standard medical care (primary care, hospitals and clinics) is 
financed from compulsory private insurance. Long-term, disease-related care is covered by 
compulsory social insurance funded by an income-related tax. Forms of care regarded as less 
necessary, such as dental care or hearing aids, are funded by voluntary supplementary health 
insurance. Public health is organised at the municipal or district level, with supervision and 
monitoring at the regional and national levels by the Health Care Inspectorate (IGZ). Reform 
over the last decade has transferred responsibility for purchasing care from government to 
insurers and increased competition between health care providers.1 
3. Cardiovascular risk factors in the population 
Smoking: 31% of men and 23% of women aged 12 years and over are current smokers.2 A target 
to reduce smoking in the population to 20% by 2010 was set, but it hasn’t been met. While a 
ban on smoking in public places has been implemented, owners of restaurants and bars are 
finding loopholes to circumvent the ban. The ministry of health is now re-examining the ban 
and looking at the possibility of using ventilators. Arguments around personal freedom are 
being raised and even the new government is questioning the extent of the smoking ban.  
Fruit/vegetable consumption: Mean daily fruit and vegetable consumption for men is 305g 
and for women is 327g.3 
Energy from fat: 37% for men and 37% for women aged 20 years and older.4 
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Physical activity: 56% of men and 55% of women aged 12 years and older meet the standard 
for healthy exercise (under-18 years – a minimum of one hour moderately intense physical 
activity daily; 18 years and over – at least 30 minutes of moderately intense activity at least five 
days a week). 2 
Overweight/obesity: 41% of men and 30% of women aged 20 and older are classified as 
overweight (BMI 25-29.2kg/m2), while 11% of men and 12% of women are classified as obese 
(BMI ≥30kg/m2).2 
Blood pressure: 27% of men and 22% of women aged 20-70 years have high blood pressure 
(≥140mmHg SBP or ≥90mmHg DBP or taking blood pressure medication; ≥160/90 mmHg  for 
people 60 years and older without diabetes mellitus, familial hypercholesterolemia or heart 
disease). 5 
Cholesterol: 12% of men and 11% of women aged 20-70 years and over have high cholesterol 
(total cholesterol ≥6.5mmol/L or taking cholesterol-lowering medication). 5  Cholesterol 
control in secondary prevention is well managed, as reflected in the EUROASPIRE results. 
4. Status of the 4th JTF Guidelines 
The principal set of guidelines for cardiovascular prevention in use in the Netherlands is a 
national guideline, the Dutch Multidisciplinary Guideline on Cardiovascular Risk 
Management 2006.6 It was developed to replace various Dutch guidelines that provided 
differing guidance on CVD prevention and was intended for use by all health care 
professionals who deal with atherosclerotic disease including cardiologists, GPs, internists, 
neurologists, vascular surgeons, vascular specialists, allied health professionals (such as 
dieticians, physiotherapists, specialist nurses in hospitals), and support staff in GP practices. 
The guideline is aimed at patients who are at increased risk or potential increased risk of CVD, 
but the screening of risk factors in the general population is outside its scope.  
The Dutch guideline incorporates and observes the guidance of the ESC 3rd JTF Guidelines, 
but there are differences in some thresholds for pharmacological treatment to take account of 
specific characteristics of the Dutch context. While medical specialists also refer directly to 
the ESC guidelines to some extent, the Dutch guideline takes precedence when it comes to 
treatment, especially as a new payment structure for doctors engaging in cardiovascular 
prevention is linked to adherence to Dutch guideline. An update of the Dutch guidelines 
incorporating the 4th JTF guidelines is currently in development.   
SCORE 
The SCORE charts were recalibrated by the guideline development group using Dutch 
mortality data. A revision of the SCORE charts using the latest epidemiological data is planned 
to accompany the updated guidelines. Some dissatisfaction with the SCORE charts was 
expressed, in particular the influence of age, which has the consequence that younger people 
whose lifestyle behaviours are poor are not considered to be at risk and do not warrant 
attention, while people over 65 years who live healthily are nevertheless considered to be at 
risk, which leads to the medicalisation of old age. It is also a weakness that they focus on 
mortality; calculating risk of morbidity might be more meaningful to patients.  
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Multidisciplinary alliance 
The Dutch guideline was developed by a multidisciplinary group assembled by the Dutch 
Institute for Healthcare Improvement (CBO) and comprised representatives of the different 
specialities that that deal with cardiovascular disease, epidemiologists and the Netherlands 
Heart Foundation. For the 2010 update, the multidisciplinary group has been broadened to 
include cardiovascular nurses and patients, reflecting the increasing role of these two groups 
in cardiovascular disease care in the Netherlands. 
In particular, patient organisations want to participate in the decision-making, to shift the 
guidelines away from scientific issues in treatment or diagnosis towards guidelines that are 
patient oriented. Hence the balance in the multidisciplinary alliance has changed; patients are 
making decisions alongside cardiovascular experts and not merely being consulted in the 
process.  
Implementation 
While responsibility for implementation rests ultimately with the different health professional 
groups, a number of initiatives in Dutch health care are driving implementation forward. 
 
A key force behind implementation is national platform, Platform Vitale Vaten (Vital Vessels), 
comprising 28 interest groups including patients' representatives, health care professionals, 
health care insurers, policymakers and scientific organisations. The aim of this alliance is to 
apply pressure to improve care for people at high risk of or with established cardiovascular 
disease. To this end, the alliance has developed a health care standard for cardiovascular risk 
management, which is effectively an implementation model for the guidelines. It uses the 
World Health Organization chronic care model as a framework to describe how to apply the 
multidisciplinary guideline in delivering optimal care for patients. The care standard focuses 
on primary prevention, emphasises the need for partnership between patient and health care 
providers, and supports the patient in self-management to reduce lifestyle risk factors. In 
addition, protocols are being agreed on a regional basis to translate the multidisciplinary 
guideline and the care standard into actual practice.   
It was noted that most power to implement the guidelines rests with the government, the 
health professionals operating in the field, and the insurance companies. In this context, a 
new payment structure for cardiovascular disease management that is aligned with the 
multidisciplinary guideline and the care model is likely to have a significant effect. Under this 
payment structure, introduced in January 2010, prevention programmes can be covered by 
health insurance companies. This was not the case previously when insurance paid for 
treatment only when disease had developed. Under the new system, patients at high risk 
(greater than 5% risk of mortality in 10 years) qualify for ‘indicated prevention’ which is 
covered by health insurance. The contract with the insurer will require practices to adhere to 
the multidisciplinary guideline and to publish quality and efficiency indicators.  In realigning 
the payment structure, there was a determination to shift cardiovascular care into a primary 
care setting and to shift payment so that it no longer follows the provider but the patient. 
Implementation of the cardiovascular prevention programmes and the payment structure that 
accompanies them is just beginning and uptake has been slow so far; similar programmes for 
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diabetes and COPD have been taken up much more quickly. It was acknowledged that it will 
take time, effort and imagination to implement such programmes. Professionals and patients 
have to get used to the idea and insurance companies have to start actively promoting them. 
To facilitate new modes of financing healthcare, the government is stimulating a shift to 
multidisciplinary team practices that cover all the competences that are needed at primary 
care level to manage chronic disease. GPs are being encouraged to come together to set up 
practices that include specialised nurses, physiotherapists where necessary, and dieticians, 
which can treat high-risk patients in the one setting. The aim ultimately is to have the 
increasing numbers of patients with chronic illness and multi-morbidity catered for in primary 
care. 
Adherence and audit 
Evaluating adherence to the cardiovascular risk management guideline and the care standard 
occurs on different fronts. At present, it is not known exactly how many cardiologists, internal 
medicine specialists, general practitioners and so on, are using the guidelines but it is starting 
to be evaluated. A questionnaire has been developed and sent to professionals to gather the 
data.  
The Health Care Inspectorate (IGZ) plays a major role in monitoring and improving 
adherence. At present, it is conducting an overview to evaluate how well prevention measures 
are implemented in all types of care. The IGZ first reviewed the literature to establish the 
factors that most contribute to health and identified smoking cessation first, exercise next and 
then weight management. On that basis, the IGZ has sent out a questionnaire to hospitals on 
how well smoking cessation programmes are implemented in myocardial infarction patients. 
In addition, the IGZ will visit some hospitals and rehabilitation clinics to investigate 
adherence to the guidelines and to address any lapses.  
Another force behind adherence are the insurance companies. Under the prevention 
programmes, insurers require programme providers to monitor a set of process and outcome 
indicators and to provide this data to the insurers through a database. This data enables the 
insurer to evaluate if care is being provided as it should be. The ICT underpinning the system 
is well organised and doctors can track their own results and compare them with those of 
doctors.   
Adherence to guidelines is likely to be improved by the development and use of decision 
support systems for cardiovascular risk management and prevention that are based on the 
guidelines. While these are not yet implemented widely, it is expected that once financial 
supports for their use are provided, they will become commonplace. It is envisaged that 
eventually standard care of patients will be provided by a nurse practitioner or physician 
assistant, who will be supported by decision support systems based on the guideline. The 
more complex patients will be treated by a doctor, where more deviations will occur because 
of the treatment challenges posed by the disease in those patients.  
Screening 
No national CVD screening programme is running at present in the Netherlands, but studies 
to evaluate the benefit of a programme are being conducted. If the findings indicate that it 
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would be effective for prevention as well as cost-effective, a programme may be established in 
the next year or two.  
The programme that is being developed intends to take a stepped approach to screening. A 
patient will begin by completing a questionnaire to establish their risk profile. If the patient 
reaches a particular cut-off value calculated from the questionnaire, an integrated risk profile 
based on SCORE and the multidisciplinary guideline will be made. If the patient reaches cut-
off value for indicated prevention, treatment will be provided by the insurance company.  
The difficulty of reaching disadvantaged groups with screening programmes was 
acknowledged and that ways to do so would have to be found for the programme to be a 
success.  
Prevention support services 
At present everybody has the right to consult a dietician 5 times for advice on diet, but very 
few people avail of it. Plans are being made to provide intervention services such as smoking 
cessation and physical activity support to high-risk patients. Under these plans patients would 
be reimbursed for services they use. The goal in the long run is to individualise prevention 
services to patients’ needs so that each patient is supported individually to improve their 
lifestyle behaviour. Free provision of such services to people was seen as being essential to 
ensure uptake. Working out funding for such programmes is a problem and it is not certain 
that these plans will be realised in the short term. 
5. Successes 
Cardiac rehabilitation 
Cardiac rehabilitation services are of a high standard. Greater numbers are being referred to 
cardiac rehabilitation and services are more tailored to patients’ needs. Services extend 
beyond physical rehabilitation to include information programmes and support for 
psychosocial problems. While the Society of Cardiology is very active in rehabilitation, it was 
felt that not all cardiologists recognise the importance of rehabilitation and that the clinical 
intervention is their main concern.  
Chronic care 
A lot of work is being done on organising care in chronic disease in the Netherlands at 
present, and the reorganisation of diabetic care provides a template for the improved care of 
patients with cardiovascular disease. Much of the care of diabetes patients has moved from the 
hospitals to primary care and has been integrated well. Much effort is being applied to 
systematically monitor the quality of their care and the expertise that is hired for different 
patient needs. Once practices have established diabetic programmes, it ought to assist them in 
expanding to incorporate cardiovascular risk programmes.  
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6. Challenges 
Role of cardiologists 
It was noted that one consequence of focussing cardiovascular care in the primary care sector 
has been an attenuation of the role of the cardiologist, and it was suggested that fewer 
cardiologists would be needed in the Netherlands in the future. A similar project to move care 
of heart failure patients into a community setting was opposed strongly by cardiologists who 
were concerned over losing control of their patients; less opposition was expressed in relation 
to prevention as they acknowledge that prevention is mainly a primary care responsibility.  
Quality of care 
A potential problem with multidisciplinary programmes based in primary care clinics is that 
the clinics may not have the expertise to cater for patients with multi-morbidity; the expertise 
for such care is still based in hospitals. The view was also expressed that many cardiovascular 
patients already in primary care do not receive the care that they should get, raising the 
question of whether the further shift towards primary care will improve quality of care.  
Payment structure 
It was acknowledged that a downside of the new payment structure for prevention is that it 
has to be managed properly if it is to avoid incentivising practitioners to expand treatment 
beyond the actual needs of the patient, which would increase health care costs in the long run. 
But it was felt that it is necessary to pay doctors to systematically engage in prevention 
because of the demands it places on them to educate and counsel patients who do not feel sick 
and are little oriented to change their lifestyles.  
Integrated care 
Integration of services for secondary prevention between GPs and hospitals is poor and 
communication between the two is lacking. This situation has been exacerbated by the new 
payment system.  
Health insurance providers 
There are implicit disincentives for insurance companies investing in prevention in the 
current system. For example, if an insurance company pays for preventive treatments for a 
patient, competitor companies will benefit from those treatments if the patient moves insurer, 
as they are free to do. In addition, the role of insurance companies will always be limited as 
they are tied to their individual clients and more can be achieved in prevention at a collective 
level, which is the responsibility of government. 
Policy and strategy 
It was planned that a new heart health strategy would be launched in 2010, but it appeared to 
have been postponed as the government has changed in the meantime.   
There is no target for the reduction of cardiovascular disease in the population; however, there 
are targets for changeable risk factors and policy to change the prevalence of these risk factors, 
with the aim of reducing the chronic disease burden.  
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Some scepticism was expressed about the targets for risk factors set in the national policy on 
health and prevention, Opting for a Healthy Life. While the policy document reflects good 
intentions, it was felt that the policy-makers have no concrete means of achieving them. So 
although goals have been written into policy, there is no further reference to them in official 
prevention discourse.  
In addition to the strategies set by the ministry of health, there are very active Dutch 
platforms working on risk factor reduction in the areas of obesity, smoking and diabetes. 
These platforms have been most successful when they have focussed on secondary prevention, 
where the condition is present. Their activities on secondary prevention have been received 
well and advanced with considerable momentum. The area of primary prevention has been 
pursued much less by these platforms. Other organisations are also active in risk factor 
reduction, for example the National Institute of Sport and Physical Activity (NISB) is working 
to improve physical activity levels in the population.  
The view was expressed, however, that the activities of these organisations do not have a 
structural impact on the health system that would gear it emphatically towards prevention 
and that responsibility for a shift of focus lies with the government and its determination to 
compel such a shift.  
7. Advice for the 5th Joint Task Force 
It was felt that 5th JTF should produce a basic European guideline that facilitates standardised 
regional adaptations, which would enable the comparison of adaptations made by different 
countries. At present, there is no standardised approach to adaptation, no tool or 
documentary protocol, so it is difficult to track the adaptations made by different countries.  
For example, it would be useful to be able to easily discover variations in treatment threshold 
values across countries.  
 
The necessity of renewing the guidelines as often as is done at present was questioned, and it 
was suggested that they will become too thick to be readable. It was felt that they should be 
updated only when new evidence emerges and then should just focus on the changes. The 
guidelines should also be more explicit about outcomes and the goals of treatment, and 
identify explicitly which type of patient should always be treated.  
 
It was suggested that a single ICT system for monitoring patients and supporting 
implementation should be distributed for free so that everyone was using the same system, a 
system that could be accessed both by professionals and patients. Several software 
programmes that do the same thing are being used at present, which wastes both time and 
money. 
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Norway 
1. Interviewees 
National coordinator Dr Tor Ole Klemsdal 
Heart foundation Mrs Carina Søderblom Alm, head of the cardiovascular section, 
Norwegian Health Association 
Health ministry Prof. Ole Frithjof Norheim, Leader of the guidelines group 
Consultation Gaps 
 Cardiac society: The cardiac society declined to participate.  
2. Health system 
The Norwegian health care system is organised on three levels – national, regional and local. 
The Ministry of Health and Care Services at national level has overall responsibility for the 
system, determining health policy and allocating funds. Five regional health authorities have 
responsibility for specialist health care, while at the local level, 431 municipalities have 
responsibility for primary health care. 
Health care is publicly provided and funded mainly through taxes. The municipalities have the 
right to levy proportional income taxes on their populations, while the regional health 
authorities receive transfers from the central government. 1  
3. Cardiovascular risk factors in the population 
Smoking: 20% of women and 21% of men aged 16 to 74 years are daily smokers, while a 
further 9% of each sex smoke occasionally. 2 
Fruit/vegetable consumption: The average daily intake of fruit, vegetables and potatoes is 
between 400 and 460g. Norway’s Health Directorate recommendation is 750g per day.3 
Energy from fat: Saturated fat represents 14% of daily energy intake. 
Physical activity: 22 % of women and 18 % of men aged 20–85 years meet the standard of 
more than 30 minutes exercise each day.4 
Overweight/obesity:  26 % of women and 43% of men are overweight (BMI 25–29.9kg/m2), 
while an additional 8% of women and 11% of men are obese (BMI ≥30kg/m2).2 
Blood pressure: The latest data on raised blood pressure was available only for some regions 
and for 40-45 year olds only; among men, it ranged from a low of 20% in Finnmark to a high of 
26% in Hedmark; among women, it ranged from a low of 9% in Finnmark to a high of 13% in 
Troms. 5 
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Cholesterol: 76% of men and 64% of women aged 40–45 years have cholesterol equal to or 
above the recommended level of 5 mmol/l.6 
4. Priorities 
Smoking has re-emerged a high priority. Norway had been particularly successful in reducing 
smoking up to the turn of the century, and as a result, concern over its prevalence had waned. 
The country has been less successful in the past decade in tackling smoking, so policy-makers 
are turning their attention to the issue once more. Stricter regulations, on the sale of tobacco 
for instance, are being considered.  
Diet and exercise are also priorities. A four-year action plan to increase physical activity in the 
population was launched in 2005. It aims to promote physical activity across different social 
sectors – schools, work, transport, local environment and leisure.  A similar intersectoral 
approach has also been adopted for the action plan on improving nutrition, launched in 2008.  
5. Status of the 4th JTF Guidelines 
Neither the 3rd nor the 4th JTF guidelines have been endorsed, published or implemented in 
Norway as key elements were found to be unsuitable for application. When the 3rd JTF 
guidelines were issued, the national coordinators could not recommend that the Norwegian 
Society of Cardiology endorse them, for two main reasons: risk was overestimated by a factor 
of almost two and the thresholds for pharmacological therapy were inappropriate in the 
Norwegian context. A paper by Getz,7 published in the BMJ, demonstrated that if the 
guidelines were to be followed, over half the population of Norway would be considered to be 
at increased risk and recommended for pharmacological treatment. 
When the 4th JTF guidelines were issued, the Society of Cardiology was prepared to endorse 
the guidelines if the risk charts could be recalibrated by the ESC with new Norwegian 
mortality data, as had been done for other countries. The society also sought to discuss with 
ESC the issue of relative risk and how the guidelines might be modified to take account of the 
influence of age on the recommendations. However, delays occurred in this process of 
engagement with the ESC, and meanwhile work initiated by the government to develop 
national guidelines had gathered momentum. This produced guidelines with new risk 
recommendations that took age into consideration, setting different thresholds for 
pharmacological treatment of 1% absolute mortality for ages between 40 and 50 years, 5% 
between 50 and 60 years, and 10% for those above 60. This remains the key difference between 
the Norwegian guidelines and the ESC guidelines.  
National guidelines 
Norway’s cardiovascular prevention guidelines, the National Guidelines for Individual Primary 
Prevention of Cardiovascular Disease8, were published in May 2009. The development of these 
guidelines was a government initiative, the aim of which was to create national guidelines 
agreed with the support of all relevant professional associations, patient organisations and 
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health management. Prior to the development of the national guidelines, separate and 
inconsistent guidelines were issued by the association of general practitioners and the Society 
of Cardiology, with GPs favouring higher thresholds than the organ specialists. 
The development process was overseen by the Health Directorate, which assembled a working 
group comprising specialists in cardiology, general practice, epidemiology and health 
economics, and representatives of patient organisations. Towards the end of the process, a 
draft of the guidelines was sent to other organisations and professional groups for comment. 
The Health Directorate and other organisations arranged several implementation conferences 
throughout the country to present and disseminate the guidelines. GPs were seen as the 
biggest and most important target group, and a series of courses specially directed at them 
with the involvement of members of the guideline working group were run. A short version of 
the guidelines has been published in the journal of the Norwegian Medical Association and 
sent by post to every practitioner in Norway, ensuring that all physicians received a copy. The 
full and short versions of the guidelines are also available on the Health Directorate website. 
The target group for the guidelines is all physicians and other health care professionals who 
provide primary prevention of cardiovascular disease, whether the treatment is started in 
primary care or by specialists in other health care services.  
Small revisions of the online version of the guidelines has taken place and a formal revision 
was recommended to take place within 3 years of their publication. 
The guidelines were broadly welcomed in the medical community and are well regarded. The 
opinion was expressed that they are accessible, useful and have raised awareness of 
cardiovascular prevention in the whole community. 
Adherence and audit 
Little is known of adherence to the national guidelines. The guidelines development group did 
discuss the need to monitor adherence, but there has been no formal assessment of this.  
Screening 
Screening programmes for cardiovascular disease operated throughout the country at a county 
level for several years. The same organisational structure that was set up for screening for 
tuberculosis was used in the 1950s and 60s to measure blood pressure and cholesterol, and 
Norwegians aged 40 years attended when invited. However, participation rates fell and the 
costs of the programmes were questioned. In the last 10 or 15 years, only some counties have 
continued with these programmes. Screening is conducted usually by teams based in the local 
university. 
Incentivisation 
Some initiatives to pay general practitioners to engage in prevention have been undertaken. A 
programme called Green Prescription was launched in 2003, under which general practitioners 
were reimbursed for giving patients advice on lifestyle changes – to improve their diet and 
exercise  levels, for example. The programme required that GPs should not prescribe any drug 
during these consultations. The scheme was not successful. Patients were unenthusiastic as 
4
th
 JTF Guidelines Implementation Review: Appendix B 
 
65 
 
there was no financial incentive for them to participate, and many doctors thought it unfair to 
exclude those who needed both medication and lifestyle advice.  
Another programme pays GPs a small fee twice a year to advise patients on smoking cessation, 
but again this was not felt to be a successful initiative.  
6. Challenges 
Risk estimation 
Issues surrounding risk estimation in the European guidelines have been the main barrier to 
the acceptance of the guidelines in Norway, in particular the estimation of risk in younger 
people. The 2003 guidelines proposed that to evaluate risk in a younger person, the physician 
should extrapolate to their age to 20 years later. However, it was found that that approach 
would result in 80 to 90% of Norwegian men over 60 qualifying for pharmacological 
treatment. While the 4th JTF guidelines provided a relative risk chart instead of extrapolating, 
it was felt that the guidelines were vague over whether this chart or the absolute risk chart 
should be used.  
The problem with total risk estimation is that age and sex have such a strong influence that a 
wide pharmacological approach will almost inevitably be recommended for men over 60 years, 
while almost no women under 50 years will have drugs recommended, regardless of risk factor 
profile.  
7. Advice for the 5th Joint Task Force 
The guidelines were commended for the recommendations they contain on lifestyle, but it was 
felt important to set an acceptable threshold for pharmacological treatment, one that is not 
offensive to physicians’ instincts. It was acknowledged that drawing a sensible line between 
patients who need drug therapy and those who don’t is the most difficult part of developing 
guidelines, and the Norwegian guidelines development group had struggled with the 
questions for four years.  
In addition, it was felt that the guidelines needed to make a better estimation of risk, taking 
account of age and sex, so that younger people with several risk factors are recommended for 
treatment. 
It was also suggested that more attention should be given to implementation. Successful 
implementation takes time and requires preparation and good resources to be put in place.   
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Poland 
1. Interviewees 
National coordinator Prof. Piotr Jankowski 
Cardiac society Prof. Piotr Jankowski, chairman of the Working Group on 
Intervention and Prevention of the Polish Cardiac Society 
Health ministry Ms Anna Kaminska, director, Department of Health Policy, 
Ministry of Health  
Consultation Gaps 
 Health service agency: No representative was identified. 
2. Health system 
The Polish health system is funded mainly through a compulsory health insurance scheme, 
the National Health Fund. Citizens who are not insured by their employers or who are self-
employed can purchase voluntary health insurance. The Ministry of Health is responsible for 
national health policy, major capital investments, standardisation of services, the 
improvement of quality control and medical education. Territorial self-government 
administrations are responsible for the budgeting, planning, organisation and supervision of 
health care at a regional level. The health system is oriented towards primary care services, 
and general practitioners (GPs) serve as gatekeepers. Hospitals are publicly owned but self-
governing and self-financing administrative units.1 
3. Cardiovascular risk factors in the population 
Smoking: 37% of men and 23% of women aged >15 years were smokers in 2006.2  
Fruit/vegetable consumption:  Poland meets the recommendation of consuming at least 
400 g of fruits and vegetables per day.3 
Energy from fat: Fats were the source of 37% of daily dietary energy in the case of men and 
35% in women aged 20-74 years according to the WOBASZ survey (2003-2005).4 
Physical activity: 40% of men and 28% of women aged 20-74 years were overweight (in 2003-
2005); 21% of men and 20% of women in the same age group were obese. 6 
Overweight/obesity: 39% of men and 24% of women aged 20-64 years were overweight in 
2002; 18% of men and 11% of women in the same age group were obese. 2 
Blood pressure: The WOBASZ survey found arterial hypertension in 42% of men and 33% of 
women aged 20-74 years, while the WOBASZ Senior survey of participants over 74 years of age 
found that 74% of men and 86% of women had hypertension.7 
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Cholesterol:: 67% of men and 64% of women aged 20-74 years had hypercholesterolemia 
(total cholesterol ≥5.0 mmol/l or LDL cholesterol ≥3.0 mmol/l) in 2003-5.8 
4. Priorities 
The smoking rate in Poland is high. While the number of male smokers has declined since the 
1990s, the numbers of young women smokers has not been reduced. A new law restricting 
smoking in public places came into force in November 2010. The law, however, fell short of the 
goals of anti-tobacco activists. It outlaws smoking in hospitals, on beaches and on public 
transport, but larger bars, cafés and restaurants, if they meet certain criteria, can designate a 
room for smokers. There are no specific targets for smoking reduction, the aim is to reduce it 
as much as possible.  
Hypertension is very prevalent in Poland and the Polish Hypertension Society has lobbied 
strongly for tackling it to be top of prevention agenda. The most frequent main risk factor in 
Poland is hypercholesterolemia.  
5. Status of the 4th JTF Guidelines 
The executive summary of the 4th Joint Task Force guidelines has been translated and 
published, without changes, as an appendix in the journal of the Polish Cardiac Society, 
Kardiologia Polska, which all members of the society receive. It was also published on the 
society’s website.  
In addition, an alliance of medical societies, the Polish Forum for Prevention, develops 
recommendations on different aspects of cardiovascular prevention based on the 4th JTF 
guidelines, which take account of the Polish context and of other relevant evidence. An 
example is the ‘Statement on the diagnosis and treatment of tobacco dependence in patients 
with cardiovascular diseases’.9 A number of papers based on the guidelines have been 
published in journals of other specialisms, such as general practice, hypertension and internal 
medicine.  
Some societies develop their own guidelines. For instance, Polish Society of Hypertension 
together with the College of Family Physicians in Poland developed guidelines on 
hypertension management based on ESH/ESC guidelines.  
Multidisciplinary alliance 
The Polish Forum for Prevention (PFP) was established in 2005 by the Polish Cardiac Society 
and other societies, which had been spurred by the publication of the 3rd JTF guidelines to 
create an alliance of experts from various national societies in the field of cardiovascular 
disease. The alliance includes the Polish Cardiac Society, the Polish Paediatric Society, the 
Polish Society of Neurology, the College of Family Physicians in Poland, the Polish Diabetes 
Society, the Polish Society of Hypertension, the Polish Society on Atherosclerosis Research 
and the Polish Society of Internal Medicine. This alliance aims to influence cardiovascular 
prevention at different levels of Polish society –to have an impact at government level through 
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health policy but also to develop knowledge of prevention among physicians, nurses and other 
health care professionals. The PFP also targets information at the general public. The PFP has 
developed websites, books and booklets to disseminate information to students, physicians 
and the general public. 
Adherence and audit 
Cardiologists are familiar with the guidelines, but it is harder to gauge the extent to which GPs 
fully engage with them. It was felt that GPs are likely to focus most on the main goals for 
cholesterol and blood pressure levels, but they may not engage with other aspects of the 
guidelines.  
No national audit of adherence to the guidelines or of prevention practices among physicians 
has been conducted or is planned. Information on adherence is available from EUROASPIRE 
surveys and studies led by Prof. A. Pająk,  Assoc. Prof. P. Jankowski, and Assoc. Prof. A. 
Windak. 
Screening 
The WOBASZ survey, the most important nation-wide survey was conducted in 2003-2005. At 
present, attempts are under way to repeat the WOBASZ survey. 
Incentivisation 
GPs can be paid a small amount by the National Health Fund to treat patients for smoking 
cessation. To participate GPs must have completed an approved course on smoking cessation, 
which is paid for by the government. They can then sign a contract with the national health 
fund to provide smoking cessation services to patients. Many GPs have signed up to this 
programme, but there has been no audit of its effectiveness. 
6. Successes 
Fruit and vegetable consumption 
A media campaign addressing lifestyle that was run under the POLKARD programme focussed 
strongly on making proper food choices. 
Outcomes 
Cardiovascular disease mortality is decreasing but at a slower rate than in the 1990s. 
Treatment of myocardial infarction is among the best in Europe. The mortality after 
myocardial infarction is quite low in Poland. This is not the case with stroke, however, and 
this difference was attributed to neurologists having a different approach to treatment.  
Cardiovascular strategy 
The POLKARD is a national cardiovascular disease prevention and treatment programme that 
has run from 2003 with the aim of reducing cardiovascular morbidity and mortality by one 
third. The programme is an action plan for the prevention, diagnosis and treatment of 
cardiovascular diseases, availability of equipment, healthcare standards and monitoring the 
changes that occur in Poland. 
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7. Challenges 
Prevention 
It is felt that policy-makers in the ministry of health are more interested in treatment than 
prevention. While Poland is performing better in the area of prevention than previously, it is 
still below par compared with other European countries. Progress is gradual; for instance, salt 
intake appears to have fallen from around 15g to 12g over the past few years. A lot of work 
remains to be done to control the cardiovascular risk at the population level, however. 
Another challenge is that the role of the GP in cardiovascular disease management is not yet 
fully developed. People with cardiovascular disease prefer to be treated by a cardiologist.  
8. Advice for the 5th Joint Task Force 
It was felt that having different European guidelines with different recommendations may 
cause confusion. Every effort should be made to have the same guidelines and the same main 
goals across European societies.  
It was not felt that the ESC has a role in communicating with the patient or members of the 
public. This is a role for local societies – the Polish Cardiology Society and other local bodies. 
Special chapters on management of risk factors in subjects with CVD would increase value of 
ESC guidelines and increase their usefulness.  
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Romania 
1. Interviewees 
National coordinator Prof. Dan Gaita 
Cardiac society Prof. Dan Gaita, president of the Working Group on Preventive 
Cardiology, Romanian Society of Cardiology 
Heart foundation Prof. Dan Gaita, president, Romanian Heart Foundation 
Health ministry Prof. Cristian Vladescu, former president of Romanian Health 
Insurance Fund and current head of the National Public Health 
School and Medical Management 
2. Health system 
The Romanian health system is based on a decentralised social health insurance model. 
Health insurance is mandatory and linked to employment, with both employers and 
employees paying insurance contributions. District health insurance funds are in charge of 
collecting insurance premiums and paying service providers within their districts. Their 
activities are regulated by the National Health Insurance House. The Ministry of Health is 
responsible for developing and implementing health policy and programs, dealing with public 
health, and coordinating the national health system. 1 
3. Cardiovascular risk factors in the population 
Smoking: 22% of people aged 18–85 years are current smokers.2  
Fruit/vegetable consumption: No data was available. 
Energy from fat: No data was available. 
Physical activity: 43% of the population engage in physical activity outside of sport regularly 
or with some regularity, while 27% never do so.3  
Overweight/obesity:  26% of the population aged 18–85 years has been classified as obese 
(BMI ≥30kg/m2).2 
Blood pressure: 50% of men and 41% of women  aged 18 years and over have hypertension 
(defined as SBP ≥140mmHg and DBP ≥90mmHg).3  
Cholesterol: 31% of the population aged 18–85 years has raised cholesterol (defined as those 
on lipid-lowering medication or with total cholesterol > 200 mg/dl).2  
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4. Status of the 4th JTF Guidelines 
The Working Group on Preventive Cardiology of the Romanian Society of Cardiology is 
responsible for the ESC prevention guidelines in Romania. The group translated the executive 
summary of the guidelines and published it in the national cardiology journal Revista Română 
de Cardiologie. The guidelines were sent out to doctors by the Ministry of Health. 
The working group has limited resources for implementation and was described as a ‘small 
club’. It has just 20 active members, 3 of whom are involved in university education. Its 
members endeavour to implement the guidelines their clinics, but are far as yet from 
achieving the targets. 
The working group has a good relationship with the national society of GPs. It aims to engage 
GPs with prevention, and to this end invites them to congresses and organises courses on 
reducing cardiovascular risk in patients.  
SCORE 
The SCORE risk calculator for high-risk countries has been translated into Romanian. The 
working group regards the SCORE charts as a key instrument for prevention and has 
attempted to distribute the charts to all GPs. 
Adherence and audit 
The group has no means to measure the effectiveness of its activities, so the extent to which 
doctors adhere to the guidelines is unknown at present.  
Screening 
A national cardiovascular screening programme was planned in 2009, whereby GPs would be 
offered a small income to select patients without existing diabetes and cardiovascular disease 
and to measure their risk using SCORE. The aim was to screen more than 100,000 people; for 
many of those screened, it would have been the first time they had received information from 
a doctor about prevention and lifestyle changes. Although the programme was originally 
allocated a budget, it was deprioritised and as a result lost it’s funding and was cancelled. 
Incentivisation 
Doctors are not reimbursed for engaging in cardiovascular prevention activities. 
Successes 
Prevention initiatives 
Despite limited support for prevention from the State, individuals and organisations are active 
in the field of prevention. An alliance for CVD prevention was formed in 2009 between 
Romanian medical societies – cardiology, diabetes, nephrology, and general practice – and the 
ministries for health and education. The alliance was motivated by the European Heart Health 
Charter and acts as a forum for the different societies within Romania to share data and 
information about their activities. It also aims to exert influence politically and to put pressure 
on the senate commission of health to take action at a national level against the main 
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cardiovascular risk factors of smoking, poor nutrition and physical inactivity. The alliance has 
begun to feel its way in the political arena and still working out how it might have an impact 
government level. The launch of the alliance generated considerable media coverage in 
Romania. 
The Society of Cardiology established the Romanian Heart Foundation in 2010 with aim of 
extending the message on prevention to the general public. It has become a member of the 
European Heart Network and is preparing campaigns to improve the cardiovascular health of 
the population. 
5. Challenges 
Lack of prevention infrastructure 
Cardiovascular prevention is poorly supported in the Romanian health system. In a country 
with a population of around 21 million there are only 3 centres for prevention and none in the 
capital Bucharest. The State does not lead on cardiovascular prevention. It is largely a 
scientific endeavour, reliant on the motivation and interest of a small group of enthusiastic 
medical professionals. While the State acknowledges the activities of the working group and is 
aware of the importance of prevention, neither it nor the district insurance funds have 
provided the financing to develop prevention services.  
There are just 1,000 cardiologists for 20 million people in Romania. These cardiologists are 
engaged mostly in treating acute cases, and prevention is of lesser priority – hence the efforts 
of the Society of Cardiology to put prevention in the hands of GPs. 
Lack of data 
Data on cardiovascular disease and risk factors in the population are scarce, so physicians lack 
awareness of its prevalence and impact. It is difficult to get a picture of the cardiovascular 
health of the country and impossible to set targets for reductions in risk factors.  
6. Advice for the 5th Joint Task Force 
The main suggestion on updating the guidelines was to aim for greater simplicity in the 
message to both GPs and the general public about risk factors. If possible, an acronym even 
simpler than the numbers 0 3 5 140 5 3 0 that is easy to memorise should be sought. It was 
acknowledged that it is difficult to set cut-off values and to agree clear-cut guidance. But if the 
basic rules about prevention were communicated, people who wanted to know more could 
refer to other sources such as their GP, cardiologist or even the Internet.  
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Russian Federation 
1. Interviewees 
National coordinator Prof. David Nieberidze 
Heart foundation Prof. Nana Pogosova, vice-president, the Russian Society for 
Cardiovascular Prevention and Rehabilitation 
Other Dr Nadir Akhmedzhanov, cardiologist, National Research Center for 
Preventive Medicine 
Consultation Gaps 
 Cardiac society and health ministry – interviews were arranged but the individuals were 
unavoidably not available on the day of the planned face-to-face meetings. 
2. Health system 
The health care system mirrors the administrative structure of the Russian Federation, with 
federal, regional and municipal levels of responsibility. There are several parallel systems of 
service provision run by the Ministry of Health and Social Development, other ministries and 
public enterprises. The population-based public health services are organized through the 
sanitary–epidemiological service system, which operates at regional and municipal levels but 
reports to the federal level. Private and semi-private services are common.1 
3. Cardiovascular risk factors in the population 
Smoking: 60% of men and 9% of women aged 18 years and over are current smokers. 2 
Fruit/vegetable consumption: 49% of men and 60% of women aged 45-69 years meet the 
WHO recommendation for fruit and vegetable consumption of 400g daily (HAPIEE study 
data, 2002-2005).3 
Energy from fat: Men (aged 45-69 years) derive 42% of their daily energy from fat, while 
women in the same age group derive 43% daily energy from fat (HAPIEE study data, 2002-
2005). 3 
Physical activity: 19% of men and 12% of women reported engaging in moderate physical 
activity (Republic of Karelia Risk Factor survey).4 
Overweight/obesity: 12% of men and 27% of women are classified as obese (BMI ≥30kg/m2). 2 
Blood pressure: 40% of men and 41% of women have high blood pressure (≥140mmHg SBP or 
≥90mmHg DBP). 2 
Cholesterol: 57% of men and 55% of women have raised cholesterol (total cholesterol 
≥5.0mmol/L). 2 
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Excessive alcohol consumption: 12% of men and 3% of women report very excessive alcohol 
consumption.1 
4. Status of the 4th JTF Guidelines 
Multidisciplinary alliance 
The multidisciplinary alliance for guideline implementation comprises the Russian Society of 
Cardiology, the Russian Society of Cardiovascular Prevention and Rehabilitation, the Russian 
Society of Hypertension, the Russian Society of Heart Failure, and the Russian Society of 
Atherosclerosis. 
Endorsement and implementation  
The alliance has endorsed and published a national version of the 4th JTF Guidelines. These 
are the first guidelines on cardiovascular disease prevention that have been published in the 
Russian Federation. The national guidelines are an adaptation of the 4th JTF guidelines to 
local requirements, with a different presentation but little deviation in terms of content. The 
main difference is that the Russian guidelines include a chapter on cardiovascular disease 
prevention in children.  
The guidelines were presented at the Russian Annual Congress of Cardiologists in October 
2010, where they generated much interest. They have also been presented at two other 
conferences on cardiovascular disease prevention and have been published in a national 
journal. A pocket version has also been published.  
Following feedback and suggestions, an updated version of the guidelines will be published 
and distributed in early 2011. The alliance hopes that the guidelines will be endorsed by other 
medical professional societies and by the health ministry. 
The alliance hopes to publish two versions of the Russian guidelines: a short, easy-reference 
version containing targets for the control of risk factors, and a long version containing 
relevant data and advice for patients for use during consultations on cardiovascular disease 
prevention. It is intended to publish the long version in the two national journals that have 
highest impact factor, Kardiologiia and Cardiovascular Therapy and Prevention.  It is also 
hoped that the national society of general practitioners will distribute the guidelines to its 
members.  
SCORE 
The promotion of the SCORE charts has occurred just in recent years. Half of cardiologists 
report using the SCORE charts, but there is some doubt about the reliability of this statistic; 
no objective evaluation of usage has been carried out.  
A Russian translation of HeartSCORE is available and efforts are in progress to recalibrate 
SCORE using Russian data. A study has found that patients respond more to HeartSCORE 
than to the paper version of the risk chart. Viewing their risk score on HeartSCORE appears to 
impress and engage patients to a greater extent, such that adherence to medication regimes is 
better and behaviour change is more likely than amongst patients who see the paper version.  
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Screening and prevention support services 
The Ministry of Public Health and Social Development in 2009 initiated a major State 
programme to create new structures in primary care to improve disease prevention in Russia. 
This programme establishes 502 ‘centres of health’, which are based on an outpatient 
polyclinic model and which the general public can attend for health checks free of charge. 
Basic measures of health – BMI, cholesterol, glucose level, blood pressure, lung function, 
cognitive function and so on – are assessed with the aim of establishing a person’s health 
status and giving them advice on how to improve their lifestyles. 
The provision of smoking cessation services is just beginning in Russia and is not widespread. 
5. Successes 
While mortality and morbidity from cardiovascular disease are high, some trends are moving 
in a positive direction. Awareness of hypertension among the general public is increasing and 
control of hypertension is also improving. The latest data indicates that 27% of the population 
have normal blood pressure (140/90), which is in line with the European average, up from 15% 
a decade ago. 
6. Challenges 
Risk factors 
Hazardous alcohol consumption and smoking are the two areas of greatest concern to 
cardiovascular prevention experts in Russia and the two priority risk factors to address. No 
specific targets have been set for reductions in these risk factors. 
Reduction in smoking may be aided by changing attitudes to health in the general public; 
being healthy is becoming more of an aspiration and smoking, poor diet and excessive alcohol 
consumption are beginning to be regarded as undesirable. 
Russia has signed the WHO Framework Convention on Tobacco Control. Smoking restrictions 
do not extend to an outright ban in public places. Cafés and restaurants are permitted to 
designate smoking and non-smoking zones. 
Control of cholesterol is poor, as reflected in the EUROASPIRE III study. Russia is top of the 
European list with elevated cholesterol. 
Psychosocial factors have a substantial impact on cardiovascular health in Russia. The 
prevalence of the common risk factors – obesity, raised cholesterol and hypertension – has not 
changed dramatically in the past 20 years while cardiovascular mortality has fluctuated in the 
same time period. These fluctuations have paralleled periods of economic or social instability 
in the country – financial default, rising poverty levels and the war in Chechnya, for example. 
Stress, anxiety and depression play a greater role in cardiovascular disease mortality compared 
with other countries. With increasing social stability in Russia, mental health problems are 
decreasing.  In 2001/2002, 71% of people reported that they lived in situations of psychosocial 
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stress of a moderate or high level; this figure has fallen to 55%. However, no adequate 
screening for mental health will be available in the new centres of health. 
Demography 
Russia is a huge country and there are substantial regional differences in all types of mortality, 
morbidity and trends in risk factors. Mortality in Russia is higher in rural areas, in part 
because some rural populations are very isolated from medical institutions and difficult to 
access for emergency services. There are also differences between south and north – mortality 
is lower in the south that it is in the north. There are also differences in mortality between the 
different ethnic groups that comprise the Russian Federation.  
Russian SCORE 
The alliance is anxious to have a Russian version of the SCORE charts that is calibrated based 
on Russian data. Data and funding are available and efforts are under way to accomplish the 
project. 
7. Advice for the 5th Joint Task Force 
It was thought to be important that the next set of guidelines distinguish between people at 
high risk of developing atherosclerotic disease and those who have established atherosclerotic 
cardiovascular disease because they are not the same. In the 4th JTF Guidelines, the two 
groups are treated together.  
It was suggested that epidemiological data from different countries be included to highlight 
similarities and differences between countries. When data is averaged across Europe, it is not 
so striking.  
It was also felt that the work done on cardiovascular disease prevention by national societies 
should be cited in these recommendations because it contributes to understanding of the area. 
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Spain 
1. Interviewees 
National coordinator Dr José Ramón González-Juanatey 
Cardiac society Dr Luis Rodríguez Padial, guidelines coordinator of the Spanish 
Society of Cardiology 
Heart foundation Dr Luis Rodríguez Padial 
Consultation Gaps 
 Health ministry: A representative of the health ministry referred us to the Society of 
Cardiology. 
2. Health system 
The Spanish health system is tax-funded and coverage reaches the entire population. It is 
decentralised to 17 autonomous communities. The Ministry of Health and Social Policy 
establishes norms that define the minimum standards and requirements for health care 
provision, has regulatory power, sets up information systems, and assures cooperation 
between national health authorities and the autonomous communities. The autonomous 
communities decide how to organise and provide health services, and implement the national 
legislation. An inter-territorial council composed of representatives of the autonomous 
communities and the state administration is in charge of promoting the cohesion of the health 
system.1  
3. Cardiovascular risk factors in the population 
Smoking: 35% of men and 24% of women aged 16 years and over are smokers.2 
Fruit/vegetable consumption: 256 kilos of fruits and vegetables are consumed per person 
per  year; the recommended is 150 kilos per capita per year. 2 
Energy from fat: No data available. 
Physical activity: 44% of men and 36% of women aged 16 and over report achieving the 
recommended amount of physical activity. 2 
Overweight/obesity: 45% of men and 29% of women aged 18 years and over are classified as 
overweight (BMI 25-29.2kg/m2); an additional 16% of men and 15% of women are classified as 
obese (BMI ≥30kg/m2). 2 
Blood pressure: In a study of adults aged >60 years, 73% had diagnosed hypertension and 13% 
showed high blood pressure without a previous diagnosis of hypertension. (Values of BP 
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<140/90 mmHg for nondiabetic subjects and <130/80 mmHg for diabetic subjects were 
considered on control.) 4  
Cholesterol: No data available. 
4. Priorities 
The Spanish Interdisciplinary Committee for Cardiovascular Disease Prevention (CEIPC) is 
responsible for the identification every three years of priority areas in cardiovascular 
prevention on which to focus health policy. The current priority areas are obesity in children, 
smoking in the young population, especially amongst young women, and salt consumption in 
certain regions of Spain. 
In relation to obesity, health strategy is concentrating on educating young people on healthy 
eating and improving the menus of school canteens.  The objective is to reduce BMI by 1 point 
in the population under 10 years of age in the next 10 years, and there is a plan to assess the 
BMI of this population every year. 
In relation to smoking cessation, the objective is to reduce smoking by 1% per year among 
young adults. The first legislation banning smoking in public places was poorly implemented, 
and it was possible to smoke in many public places such as restaurants, bars and pubs. Much 
stronger legislation restricting smoking came into operation in January 2011.  
There is also a salt reduction target to reduce the amount of salt in bread by 1g per kilo each 
year.   
5. Status of the 4th JTF Guidelines 
Multidisciplinary alliance 
The CEIPC is a multidisciplinary alliance responsible for endorsing cardiovascular prevention 
guidelines and developing policies for their implementation. It comprises 15 medical societies 
and includes a representative each of the Spanish Ministry of Health and the Carlos III Health 
Institute.  The committee was established and is funded by the Ministry of Health.  
Endorsement and implementation 
The CEIPC has reviewed and endorsed the 4th JTF Guidelines and has adapted them for Spain 
and developed a pocket version; these activities were funded by the Ministry of Health. The 
Spanish guidelines focus on primary prevention and emphasise the role of general 
practitioners and practice nurses in managing cardiovascular risk factors.  
To disseminate the guidelines to all the relevant specialties, the guidelines have been 
published in a number of Spanish medical journals. They have not been sent out to individual 
doctors, but they can be accessed online and printed out. Different aspects of the guidelines 
have been presented by the Spanish Society of Cardiology in various meetings. 
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No other guidelines are in use in Spain and it is felt that having a single set of guidelines is an 
important step to achieving consistency in decision-making on treatment.  
SCORE 
SCORE has been recalibrated for the Spanish population. The guidelines promote the use of 
SCORE charts in risk evaluation, and the CEIPC develops policies to increase the use of 
SCORE in primary care to calculate patients’ cardiovascular risk, to record in the clinical 
record and to use it to guide treatment.  
Adherence and audit 
No systematic audit of the uptake and adherence to the guidelines has been carried out. It is 
felt that larger hospitals may be performing better in relation to guidelines. General 
practitioners are a heterogeneous group and it is unclear to what extent they are adhering to 
the guidelines. Three studies have been carried out to examine different aspects of guideline 
adherence, such as the use of the SCORE charts among primary care physicians. 
The potential for auditing exists in the health care system, however, as the majority of general 
practitioners record patient data in a computer-based patient record system. This system 
could be used to gather information on doctors’ treatment practices and the control of risk 
factors in patients. 
6. Challenges 
Administrative structure 
Spain comprises 17 autonomous communities, each of which develops its own health policies 
and strategies. This presents an impediment to guideline implementation as the CEIPC must 
deal with regional health ministries separately. While the scientific societies have engaged 
well with the Ministry of Health, a major objective of the CEIPC is to engage with regional 
governments in order to translate guideline recommendations into regional health policy. This 
aim is facilitated by the presence of chapters from each of the scientific societies in each 
region. 
Administrative priorities 
There is little incentivisation of doctors to engage in prevention, apart from isolated 
programmes implemented on a regional level. In fact, the focus of regional ministries of health 
on controlling GP spending without in parallel examining the quality of patient care might 
deter GPs from engaging in prevention activities and controlling risk factors in order to keep 
spending in practices low.   
Attitudes and habits 
Lack of knowledge of prevention was not seen as a barrier to guideline implementation, but it 
was felt that the habits and attitudes of doctors needed to change so that they regard 
prevention as a priority. Patients will not begin to take prevention seriously unless their 
doctors do so first. Understanding how to change the behaviour of doctors and of patients was 
felt to be a substantial challenge. 
4
th
 JTF Guidelines Implementation Review: Appendix B 
 
83 
 
Guidelines 
It was felt that the current guidelines are clear, much more so than the previous guidelines, 
and approval was given to their increasing alignment with the American guidelines. Spanish 
cardiologists previously used to find the American guidelines more useful. Criticisms of the 
guidelines were that they are too long, that they are not easy to use during consultations, and 
that doctors have too many guidelines to follow. It was also thought to be problematic that 
different guidelines are inconsistent in their objectives for the same risk factor, and sometimes 
the one society issues different guidelines on the same risk factor. This creates confusion and 
leads to inconsistency of application amongst physicians and acts as an excuse for 
practitioners to do what they prefer. 
7. Advice for the 5th Joint Task Force 
Assessing physician performance and adherence to guidelines is seen as important. In the 
absence of assessment, doctors cannot judge their performance or benchmark it against their 
colleagues. It was suggested that assessment could be achieved using a computer-based 
performance assessment system that would monitor symptoms in patients and indicate 
whether their risk profile was improving.  The American Heart Association’s Get with the 
Guidelines programme was mentioned as a model that should be considered. While the scope 
of the system could be narrow confined to individual hospitals or regions, it could operate also 
on a national or European level.  
Including decision support in the performance assessment system might increase efficiency 
and assist physicians in adhering to the guidelines. It was noted that referring to guidelines on 
paper during patient consultations is awkward.  
It was suggested that the focus of the ESC and other cardiovascular societies should shift from 
individual risk factor guidelines to developing a single European prevention guideline. The 
evidence is that more benefit can be achieved by reducing risk in several risk factors than by 
strictly controlling a single risk factor. The focus on individual risk factors, it was suggested, is 
a result of pressure from industry and was particularly apparent in relation to hypertension 
guidelines.  
Other advice on improving the guidelines was as follows: 
 Keep the guidelines short, with a clear message. Provide a summary document where 
the objectives for overall risk and particular risk factors for doctors are clear. 
 Put more emphasis on lifestyle changes in preference to medication in preventing 
disease. In the current guidelines that message is not so clear. 
 Have a single clear target number for the control of each risk factor.   
 Produce more algorithms that allow clear, practical conclusions to be drawn, in 
preference to tests, which are difficult to read.  
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 Develop two additional sets of guidelines – one for the general public, the other for 
health professionals and social care workers – alongside the clinical practice 
guidelines. These documents should be short with simple, clear information  on 
preventing cardiovascular disease. The version for the general public should 
concentrate on giving clear information about lifestyle changes.  
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Sweden 
1. Interviewees 
National coordinator Prof. Joep Perk 
Cardiac society Dr Kristina Hambraeus, chair of the Swedish National Registry for 
Secondary Prevention after AMI, Swedish Society of Cardiology 
Health ministry Ms Kristina Eklund, National Guidelines Unit, National Board of 
Health and Welfare 
Consultation Gaps 
 Heart foundation: Both the Swedish Heart and Lung Patients Association and the Swedish 
Heart Lung Foundation declined to participate on the basis that they have no role in 
guideline implementation. 
2. Health system 
Sweden has a public health care system, funded mainly through taxation, that covers the 
entire resident population. It is heavily decentralised and organised in three levels: national, 
regional, and local. On the national level, the Ministry of Health and Social Affairs is 
responsible for setting health care policy and ensuring that the system runs efficiently. The 
National Board of Health and Welfare is the government’s central advisory and supervisory 
agency for health and social services. On the regional level, 21 county councils provide and 
finance health care services. At local level, the 290 municipalities are responsible for delivering 
and financing social welfare services.1 
3. Cardiovascular risk factors in the population 
Smoking: 14% of men and 18% of women aged 16 to 84 years are daily smokers. Smoking was 
banned in public places in 2005.2 
Fruit/vegetable consumption: 5% of men and 14% of women aged 16–84 years consume 
500g or more of fruit or vegetables daily (corresponding to the national goal).3 
Energy from fat: 34% of daily energy is derived from fat for both men and women.4 
Physical activity: 49% of men and 53% of women aged 16–84 years take exercise at least twice 
a week. 2 
Overweight/obesity:  52% of men and 36% of women aged 16-84 years are overweight 
(including obese), having a BMI ≥ 25kg/m2; 11% of men and 10% of women are obese (BMI 
≥30kg/m2). 2 
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Blood pressure: 20% of both sexes have raised blood pressure (defined as SBP ≥160mmHg 
and DBP ≥95mmHg).3 
Cholesterol: No data available.  
4. Status of the 4th JTF Guidelines 
A summary in Swedish of the 4th JTF guidelines was published in the Swedish Medical 
Journal, which all doctors receive, and on the website of the Swedish Society of Cardiology. 
The summary referred readers to the main document in English if they wished to have further 
detail. It was felt sufficient to communicate the main message of the guidelines in the local 
language; a translation of the full document would have involved unnecessary effort and 
expense because doctors in Sweden are quite fluent in English.  
Multidisciplinary alliance 
A concerted effort was made to form a task force for implementation of the guidelines at 
EuroPRevent 2009. The Ministry of Health and Social Affairs, the National Institute of Public 
Health, and the heart foundations were interested in the idea, but the general practitioners 
(GPs) were reluctant to participate. GPs believe that preventive cardiology is their field and 
that the role of cardiologists is in the hospital setting. There is a feeling amongst GPs that 
cardiologists are the fingertips of the pharmaceutical industry and that cardiologists leading 
prevention endeavours would emphasise drug therapies in primary prevention. 
It was felt that the absence of a formal alliance has not been a barrier to implementation of the 
guidelines. There is general agreement on prevention among the different stakeholder 
organisations and they work together.  
Endorsement and implementation 
The role of the Swedish Society of Cardiology in implementation is mainly to organise three 
national meetings on the guidelines; one of these is for all physicians in Sweden, and the other 
two are more specifically directed at cardiologists and other personnel working in cardiology. 
While the society has accepted the guidelines, it has not formally endorsed them. It has been 
proposed that the working groups within the society should endorse the different guidelines 
that are issued, but no procedure for doing so has been established. 
While the cardiac societies are important in disseminating the guidelines to cardiologists, the 
Swedish Association of General Practice (SFAM) is particularly important for disseminating 
information to general practitioners because the area is much less structured than cardiology, 
making GPs harder to reach. In order to have the guidelines accepted by GPs, it was felt that 
they should be adapted to GPs’ practical needs by being summarised and fitted on a single A4 
page. They should also be seen to be owned by SFAM, even if they originated from a 
collaborative European effort. Funding for this format was not thought to be a potential 
barrier. If an agreed summary could be produced, it would be a simple task to translate it and 
have it published on the society’s website at little if any cost.  
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It was felt that the key to success in implementation is the quality of the document, that ‘a 
good publication spreads itself’. The aim of the ESC guidelines should be to be explicit and 
unambiguous, to give the latest appraisal of new knowledge that physicians can put into 
practice in their own clinical work. 
Other guidelines 
The main guidelines in use in Sweden are the National Guidelines on Cardiac Care 2008, 
developed by an expert group appointed from different specialities by the National Board of 
Health and Welfare, a government agency under the Ministry of Health and Social Affairs. 
These guidelines were submitted prior to publication for comment to several organisations 
and societies. Involving societies in this way was a strategy for disseminating the national 
guidelines and encouraging acceptance of them among the different specialities and societies. 
The national guidelines are comprehensive, covering each aspect of cardiovascular disease 
including prevention, and are strongly promoted by the health ministry. They are based on 
several sources, including the ESC guidelines and the SCORE charts. Compared to the ESC 
guidelines, the Swedish national guidelines have a broader macroeconomic perspective and  
set priorities that are somewhat different in terms of the implementation of certain health care 
measures. The national guidelines aim for the most efficient use of health care resources and 
rank recommendations according to need based on an ethical platform. In addition, the 
guidelines are aimed more at the decision-makers in health care rather than individual 
physicians. Nevertheless, they are used regularly by a majority of cardiologists.  
In addition to the national guidelines, there are also regional and local guidelines.  
Role of the ESC 
The ESC was not seen to have a role in the implementation of guidelines nationally because 
that is strictly the responsibility of the Ministry of Health and Social Affairs, and physicians 
would reject a document issuing from an external, European body. The role of the ESC is to 
provide the scientific basis for the guidelines and then to pass them to national bodies for 
implementation. A national implementation committee instigated by the ESC would simply 
compete with existing bodies and cause confusion.  
Adherence and audit 
No audit of how well Swedish doctors adhere to the ESC guidelines has been performed. The 
health ministry would not facilitate an audit under the auspices of the ESC as it has assumed 
the main responsibility for cardiovascular guidelines. One upshot of the absence of audit, it 
was felt, was an ongoing and substantial distance between practice and guidelines.   
The National Board of Health and Welfare conducts an Open Comparison and Assessment of 
Cardiac Care every 5 years to evaluate whether care is being delivered in line with the national 
guidelines. It uses 45 indicators covering acute coronary syndrome, arrhythmia, heart failure, 
valvular heart diseases, and congenital heart diseases to assess the quality of care at national, 
county and hospital levels.  
Performance in prevention in hospitals is monitored through the national cardiac registries, 
which collect data from most hospitals on acute cardiac care, diabetes and, more recently, 
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secondary prevention. Data from these sources is published yearly. The national registries 
have been able to show differences in care between hospitals and these differences have 
decreased over time, mainly for the acute treatment of myocardial infarction. The newer 
secondary prevention registry, set up in 2005, still reflects variation in care.  
Screening 
There is no national cardiovascular disease screening programme, although screening 
programmes are running in some regions. 
Incentivisation 
In some regions a financial reward is offered in hospitals if the national guidelines are followed 
as reflected by the cardiac registry. Such rewards are not offered in general practice; however, 
there is reimbursement for engaging in prevention in primary care. The rules are more 
stringent for private primary care centres than for public centres.   
5. Successes 
Sweden has been quite successful in the area of prevention. Several GPs have taken up SCORE 
and the risk management system. Publications on the guidelines in the professional press have 
been good, and physicians have taken the message on board.  
6. Challenges 
Risk factors 
Obesity, especially obesity in children, is of concern as is the prevalence of smoking among 
young women. Both these issues have given rise to debate within Sweden. Smoking has been 
banned in public places, and there have been some proposals to lower the price of fruit and 
vegetables and to raise the price of confectionary and fast food, but no legislation has been 
introduced so far. Sweden is the only country within the EU that has not adopted the free 
provision of fruit and vegetables to schoolchildren and students in spite of the EU 
recommendation. 
Engaging with general practitioners 
Engaging at the primary care level is a main challenge for guideline implementation. The 
national guidelines are not used to the same extent by GPs as they are by cardiologists.  These 
guidelines are not ideal for use by GPs as the document is detailed and dense, covering every 
aspect of cardiac care, not all of which are relevant to GPs. Some GPs are familiar with and use 
the ESC guidelines, and the SCORE charts particularly. It was felt that disseminating the 
guidelines to GPs is very much dependent on the enthusiasm of individual coordinators at a 
regional level. SFAM has not issued any national guidelines to its members. In regions where 
regional or local guidelines have been developed, GPs are likely to use those; otherwise the 
decision is personal.  
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The view was expressed that there are differences between cardiologists and GPs in the way 
they approach prevention: cardiologists are more willing to treat patients with drugs to 
prevent disease, while GPs are more resistant to using drugs and focus more on lifestyle 
changes. 
Guideline fatigue 
The excess of cardiovascular prevention guidelines – ESC, national, regional and local – was 
thought to be a significant barrier to guideline implementation. Guideline fatigue is a problem 
among physicians in Sweden, particularly among GPs since they encounter so many different  
diseases. In the profusion of different CVD prevention guidelines, doctors  tend to withdraw, 
ignore the guidelines and continue as they have done before. However, it was felt that because 
the ESC guidelines are clear, well presented and communicated effectively, physicians will 
tend to favour them, and refer to them to discover what’s new and what’s essential that they 
can implement in practice, putting the issues of competing guidelines to one side. It was 
acknowledged that while a lot of effort is invested in producing guidelines, aside from a few 
new points, nobody cares about the rest.  
7. Advice for the 5th Joint Task Force 
It was felt that the 5th JTF must aim to have a much more succinct document as the guidelines 
threaten to get excessively long. They should comprise one core document of 50 pages at 
most, focussing on what is new and useful, and a summary that distils the main conclusions 
onto an A4 page that can be attached to a wall or put on a desk.  
A good document is critical to the success of the guidelines, it was suggested. The guidelines 
should avoid the ‘cookery book’ approach and focus on answering the basic questions in 
prevention, as well as including evidence from new research findings, new recommendations 
that have developed since the last guidelines were issued, and indicating areas where large 
gaps in evidence still exist.  
It was also thought to be important that the 5th JTF guidelines should be consistent with 
other guidelines so that there should be no conflict among the guidelines for hypertension, 
diabetes, kidney disease, and so on.  
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United Kingdom 
1. Interviewees 
National coordinator Dr Susan Connolly, consultant cardiologist, Imperial College 
Healthcare NHS Trust 
Heart foundation Dr Mike Knapton, associate medical director, British Heart 
Foundation 
Health service agency Professor Roger Boyle CBE, national director for heart disease and 
stroke, Department of Health/National Health Service 
Health ministry Professor Roger Boyle CBE, national director for heart disease and 
stroke, Department of Health/National Health Service 
2. Health system 
The United Kingdom has a public health system, which is delivered through the National 
Health Service (NHS). Each of the constituent countries – England, Wales, Scotland and 
Northern – is responsible for its own health care. The NHS in each country is funded through 
national taxation and delivers services through public providers. Local bodies are responsible 
for purchasing patient care: primary care trusts (PCTs) in England, local health boards (LHBs) 
in Wales, health boards in Scotland, and primary care partnerships in Northern Ireland. The 
National Institute for Health and Clinical Excellence (NICE) provides guidance in England and 
Wales on the effectiveness and cost-effectiveness of services and whether they should be made 
available to all or part of the population.1 
An NHS white paper published in July 2010 instigates the replacement of PCTs with consortia 
of GPs responsible for managing their own budgets and commissioning treatment for patients 
in hospitals. Six additional white papers have been published around information, choice, 
commissioning and outcomes in health care. A white paper on public health in November 
2010 sets out the government’s long-terms plans on reforming the public health service in 
England. It has been suggested that the NHS might pay for this England only as Scotland, 
Wales, and Northern Ireland have different arrangements.  
3. Cardiovascular risk factors in the population 
Smoking: 22% of men and 21% of women in Great Britain (England, Wales and Scotland) aged 
16 years and over are smokers.2 
Fruit/vegetable consumption:  Total consumption of fruit and vegetables by men aged 19 
years and over in the United Kingdom is 234g per day; among women, the figure is 253g 
per day.3 Recommended daily consumption is 400g. 
Energy from fat: Total fat comprises 36% of food energy intake for men and 35% for women 
aged 19 years and over in the United Kingdom. 3 
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Physical activity: 39% of men and 29% of women aged 16 years and over in England spent 30 
minutes or more in activities of at least moderate intensity on five or more days per week.4 
Overweight/obesity:  45% of men and 27% of women aged 19 years and over in the UK are 
classified as overweight; an additional 24% of men and 32% of women are obese. 3 
Blood pressure: 31% of men and 28% of women aged 16 years and in England have 
hypertension. (Hypertension is defined as SBP ≥ 140mmHg, DBP ≥ 90mmHg, or taking 
treatment for blood pressure.)5 
Cholesterol: 57% of men and 61% of women aged 16 years and over in England have a raised 
total cholesterol level (5.0 mmol/l or above). 5 
4. Status of the 4th JTF Guidelines 
The 4th JTF guidelines have not been implemented in the countries of the United Kingdom. 
Two sets of guidelines are in use in England, Wales and Northern Ireland: the NICE 
guidelines6 and the second Joint British Societies’ guidelines (JBS 2)7. In Scotland, the Scottish 
Intercollegiate Guidelines Network (SIGN) guidance is used. GPs in England and Wales use 
NICE guidelines as these are tied to targets and remuneration. 
The NICE guidelines are a suite addressing the different conditions such as hypertension and 
hypercholesterolaemia as well as topics such as interventions on physical activity, smoking 
cessation, and diet. On the other hand, the JBS2 guidelines, developed by six professional 
societies, take an integrated approach to cardiovascular disease prevention. The NICE 
guidelines are endorsed by the Department of Health, but the JBS 2 are not. However, the two 
sets of guidelines are complementary. 
The JBS 2 guidelines are being updated (JBS 3) and whether they will be endorsed by the 
Department of Health has not been established yet, although a Department representative sits 
on the committee. A development with JBS 3 is the calculation of lifetime risk and heart age. 
The working group is working with risk communication experts on the best format to present 
this information in order to most effectively communicate risk to people. The guidelines will 
be disseminated through the British Cardiovascular Society and the British Heart Foundation. 
They will be published in the journal Heart and will available on the web. 
Risk assessment 
Two risk assessment calculators are used in England and Wales: the JBS 2 charts, which are 
based on the Framingham model, and QRISK , which is based on the GP database in the 
United Kingdom and includes all the Framingham factors plus social deprivation, ethnicity, 
treatment for hypertension, and rheumatoid arthritis. JBS 3 charts are being developed at 
present, with the aim of having them available in early 2011. The updated charts are likely to 
use QRISK2 because that has been validated in the United Kingdom and there is more 
confidence in its accuracy. In addition, QRISK2 takes account of ethnicity, which is important 
as 9% of the population is Black or Minority Ethnic. Risk is not uniformly distributed across 
the population; it clusters in families, in minority ethnic groups (particularly South Asians) 
and among groups at the lower end of the social gradient.  
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While the choice of risk assessment tool was felt to be important, the first step of getting 
physicians to start using those tools for systematic risk factor assessment was seen to be more 
so. 
Adherence and audit 
GP adherence to the NICE guidelines is high as it is tied to remuneration. Audit of adherence 
in primary care and hospitals is carried out by the Care and Quality Commission (formerly the 
Healthcare Commission). 
Screening 
A multi-factorial approach drives risk assessment in England and Wales. The estimation of 
total cardiovascular risk, rather than focusing on individual risk factors, was suggested by the 
National Service Framework in 2000 and reiterated in JBS 2 in 2005. However, the concept was 
not taken up until more recently – after the publication in 2009 of NICE guidance on lipid 
assessment and the DoH strategy Putting Prevention First, both of which put total risk 
estimation at the fore. Putting Prevention First set out the plans for the NHS to introduce a 
systematic and integrated programme of cardiovascular risk assessment and management for 
those aged between 40 and 74 years. This was a stimulus to PCTs to move from opportunistic 
screening for risk to systematic screening. 
Incentivisation 
Incentivisation of prevention is very much silo based, i.e. focussed on individual risk factors, in 
particular hypertension. The result is that people are put on registers, but their overall 
cardiovascular risk is not measured. A register for high total CVD risk is needed. The primary 
prevention programmes currently in existence are fragmented. The GP will give patients a diet 
sheet, referral to smoking cessation, referral to exercise, and referral to community dietetics. 
However, an integrated approach is lacking. 
5. Successes 
Mortality rates 
Cardiovascular disease mortality in England has fallen to the extent that it is no longer the 
leading cause of death; it has fallen to second place behind cancer. This is not the case in the 
other countries of the United Kingdom. 
Government programmes/initiatives  
 The NICE guidance on the prevention of cardiovascular disease at population level 
published earlier in 2010 was felt to have been very useful. It emphasises the importance of 
factors such as education, environment, and building policies instead of the individual with 
heart disease or risk.  
 The Marmot Review of Health Inequalities8 was also noted as important, and it was hoped 
that the public health service under the new administration would adopt it.  
 The new government has set up a series of groupings under the heading of ‘Responsibility 
Deals’. The Responsibility Deal aims to bring industry, professions, and public together to 
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address public health problems that cannot be solved by regulation and legislation. There 
are Responsibility Deals on smoking, obesity, and diet.  
 The Change4Life programme aims to create a large social movement towards living 
healthier lives, with the emphasis on good diet and physical activity. The programme has 
funding until March 2011, so its future is uncertain at present. 
British Heart Foundation programmes/initiatives  
 Hearty Lives, a programme aimed at tackling the uneven distribution of heart disease and 
premature mortality in communities. The approaches the BHF wishes to take are outside 
the scope of the NHS, so it is working with local authorities and community development 
organisations on approaches to address risk in these populations.  
 The Heart HelpLine provides information, support and advice to the general public on 
heart health. 
 Heart Matters is a free service for individuals that aims to provide tailored advice, 
information, and support to people who want to improve their heart health and reduce 
their risk. It includes, for instance, a lifestyle assessment and a bimonthly magazine. The 
service is not intended to substitute for full cardiovascular assessment but to complement 
it and motivate people. The service has around 200,000 members. 
 The Foundation has worked on cardiac rehabilitation in hospitals to offer eligible patients 
menu-based options around rehabilitation, of which secondary prevention is a part.  
6. Challenges 
Health inequality 
The overall cardiovascular disease statistics that show a reduction in mortality and morbidity 
conceal the social gradient in heart health. The difference between the healthiest and least 
healthy is stubbornly not closing and may be widening in the UK.   
Cardiac rehabilitation 
There is a prioritisation in the secondary sector towards treating the acute event, and cardiac 
rehabilitation is a lesser concern. Cardiologists assume, not unreasonably it was suggested, 
that ‘prevention’ can be picked up by primary care.  
7. Advice for the 5th Joint Task Force 
It was suggested that the 4th JTF guidelines are too focused on delivering the detailed scientific 
basis for every clinical recommendation,  which makes them difficult to work with. The 5th JTF 
should try to produce a more practical document, one that would really assist clinicians 
without being too lengthy.  
The importance of considering prevention of cardiovascular disease both in a clinical or 
healthcare setting and at a public health level was emphasised. It was also felt that more 
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account should be taken of the psychosocial factors that play a role in adherence to treatment. 
This aspect of implementation was seen as often forgotten. For instance, it is easy for a 
physician to say “Take your statins” but the next  guidelines must address the evidence on 
motivating people to change and the degree to which they can, as well as the importance of 
individual choice.  
The guidelines should also consider the mechanisms in the health service that impede or 
support implementation. Change in the health service is agonisingly slow, so the factors at an 
organisational level and an individual level that enables them to change need to be identified. 
For example, in general practice one of the major factors that has supported change has been 
computerisation of medical records. 
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